GO Type |
GO Category |
GO Term |
No. of Plants |
No. of Medicinal Plants |
No. of Food Plants |
No. of Human Edible Plants |
No. of Agricultural Plants |
No. of Garden Plants |
BP |
GO:0008283;cell proliferation |
GO:0008284;positive regulation of cell proliferation
|
535 |
287 |
21 |
168 |
0 |
14 |
BP |
GO:0008152;metabolic process |
GO:0055114;oxidation-reduction process
|
963 |
465 |
23 |
299 |
1 |
27 |
BP |
GO:0008152;metabolic process |
GO:0097267;omega-hydroxylase P450 pathway
|
1962 |
920 |
74 |
560 |
1 |
38 |
BP |
GO:0008152;metabolic process |
GO:0046777;protein autophosphorylation
|
946 |
455 |
21 |
282 |
0 |
25 |
BP |
GO:0008152;metabolic process |
GO:0006703;estrogen biosynthetic process
|
188 |
103 |
9 |
66 |
0 |
6 |
BP |
GO:0008152;metabolic process |
GO:0019373;epoxygenase P450 pathway
|
1914 |
909 |
73 |
539 |
1 |
38 |
BP |
GO:0008152;metabolic process |
GO:0009404;toxin metabolic process
|
1664 |
783 |
59 |
467 |
1 |
33 |
BP |
GO:0032502;developmental process |
GO:0031100;animal organ regeneration
|
527 |
269 |
20 |
169 |
0 |
9 |
BP |
GO:0040011;locomotion |
GO:0030335;positive regulation of cell migration
|
270 |
130 |
8 |
73 |
0 |
7 |
BP |
GO:0008152;metabolic process |
GO:0018108;peptidyl-tyrosine phosphorylation
|
976 |
458 |
18 |
283 |
0 |
21 |
BP |
GO:0002376;immune system process |
GO:0030097;hemopoiesis
|
82 |
35 |
1 |
22 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0018894;dibenzo-p-dioxin metabolic process
|
1651 |
780 |
59 |
468 |
1 |
32 |
BP |
GO:0008152;metabolic process |
GO:0006730;one-carbon metabolic process
|
2564 |
1254 |
93 |
750 |
3 |
65 |
BP |
GO:0008152;metabolic process |
GO:0008610;lipid biosynthetic process
|
200 |
101 |
7 |
63 |
0 |
3 |
BP |
GO:0008152;metabolic process |
GO:2001300;lipoxin metabolic process
|
315 |
160 |
11 |
96 |
0 |
6 |
BP |
GO:0032502;developmental process |
GO:0007568;aging
|
791 |
369 |
24 |
229 |
0 |
16 |
BP |
GO:0065007;biological regulation |
GO:0048872;homeostasis of number of cells
|
250 |
113 |
9 |
69 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:0051897;positive regulation of protein kinase B signaling
|
396 |
200 |
18 |
122 |
0 |
6 |
BP |
GO:0008152;metabolic process |
GO:0038083;peptidyl-tyrosine autophosphorylation
|
370 |
178 |
16 |
104 |
0 |
6 |
BP |
GO:0050896;response to stimulus |
GO:0009611;response to wounding
|
216 |
117 |
12 |
68 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:0070301;cellular response to hydrogen peroxide
|
544 |
282 |
20 |
176 |
0 |
14 |
BP |
Unclassified; |
GO:2000021;regulation of ion homeostasis
|
256 |
143 |
14 |
82 |
0 |
8 |
BP |
GO:0051179;localization |
GO:2001225;regulation of chloride transport
|
357 |
156 |
10 |
99 |
1 |
6 |
BP |
GO:0040011;locomotion |
GO:0014911;positive regulation of smooth muscle cell migration
|
55 |
28 |
2 |
17 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0015701;bicarbonate transport
|
2446 |
1194 |
89 |
713 |
3 |
58 |
BP |
GO:0009987;cellular process |
GO:0006286;base-excision repair, base-free sugar-phosphate removal
|
653 |
342 |
30 |
200 |
0 |
18 |
BP |
GO:0048511;rhythmic process |
GO:0048511;rhythmic process
|
153 |
64 |
7 |
49 |
0 |
3 |
BP |
GO:0008152;metabolic process |
GO:0045740;positive regulation of DNA replication
|
285 |
134 |
11 |
90 |
0 |
4 |
BP |
GO:0050896;response to stimulus |
GO:0046686;response to cadmium ion
|
115 |
47 |
2 |
31 |
0 |
4 |
BP |
GO:0008152;metabolic process |
GO:0070988;demethylation
|
227 |
109 |
9 |
71 |
0 |
6 |
BP |
GO:0009987;cellular process |
GO:0032849;positive regulation of cellular pH reduction
|
1671 |
819 |
67 |
487 |
1 |
37 |
BP |
GO:0009987;cellular process |
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling
|
70 |
40 |
1 |
30 |
0 |
1 |
BP |
GO:0022610;biological adhesion |
GO:0051894;positive regulation of focal adhesion assembly
|
285 |
145 |
12 |
90 |
0 |
5 |
BP |
GO:0009987;cellular process |
GO:0071363;cellular response to growth factor stimulus
|
254 |
121 |
6 |
77 |
0 |
2 |
BP |
GO:0008283;cell proliferation |
GO:0048661;positive regulation of smooth muscle cell proliferation
|
75 |
38 |
0 |
23 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0046427;positive regulation of JAK-STAT cascade
|
63 |
35 |
0 |
28 |
0 |
1 |
BP |
GO:0032502;developmental process |
GO:0045766;positive regulation of angiogenesis
|
126 |
69 |
6 |
49 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0030307;positive regulation of cell growth
|
27 |
15 |
1 |
9 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity
|
167 |
90 |
5 |
61 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0043406;positive regulation of MAP kinase activity
|
168 |
89 |
7 |
58 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:2000352;negative regulation of endothelial cell apoptotic process
|
36 |
20 |
0 |
12 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0046718;viral entry into host cell
|
189 |
89 |
6 |
65 |
0 |
6 |
BP |
GO:0009987;cellular process |
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
42 |
25 |
1 |
14 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051902;negative regulation of mitochondrial depolarization
|
38 |
22 |
2 |
11 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0002009;morphogenesis of an epithelium
|
131 |
65 |
4 |
50 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle
|
49 |
23 |
0 |
14 |
0 |
1 |
BP |
Unclassified; |
GO:0006461;protein complex assembly
|
58 |
34 |
3 |
18 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0051591;response to cAMP
|
77 |
33 |
2 |
20 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0042307;positive regulation of protein import into nucleus
|
85 |
39 |
0 |
31 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0045930;negative regulation of mitotic cell cycle
|
23 |
11 |
0 |
6 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1903243;negative regulation of cardiac muscle hypertrophy in response to stress
|
217 |
102 |
5 |
66 |
0 |
3 |
BP |
GO:0032501;multicellular organismal process |
GO:0007435;salivary gland morphogenesis
|
282 |
128 |
5 |
78 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0043066;negative regulation of apoptotic process
|
834 |
383 |
19 |
236 |
0 |
22 |
BP |
GO:0009987;cellular process |
GO:0035690;cellular response to drug
|
152 |
67 |
6 |
30 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway
|
105 |
52 |
4 |
28 |
0 |
3 |
BP |
GO:0050896;response to stimulus |
GO:0034614;cellular response to reactive oxygen species
|
159 |
73 |
6 |
37 |
0 |
5 |
BP |
GO:0009987;cellular process |
GO:0097237;cellular response to toxic substance
|
59 |
23 |
3 |
11 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0045429;positive regulation of nitric oxide biosynthetic process
|
189 |
85 |
7 |
48 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0071310;cellular response to organic substance
|
160 |
77 |
8 |
37 |
1 |
8 |
BP |
GO:0065007;biological regulation |
GO:0010817;regulation of hormone levels
|
139 |
67 |
11 |
36 |
0 |
4 |
BP |
GO:0065007;biological regulation |
GO:0055081;anion homeostasis
|
13 |
11 |
2 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0071248;cellular response to metal ion
|
7 |
5 |
1 |
3 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0042593;glucose homeostasis
|
21 |
13 |
2 |
4 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0033993;response to lipid
|
302 |
165 |
14 |
107 |
0 |
9 |
BP |
GO:0008152;metabolic process |
GO:0016098;monoterpenoid metabolic process
|
1256 |
594 |
36 |
347 |
0 |
13 |
BP |
GO:0050896;response to stimulus |
GO:0042738;exogenous drug catabolic process
|
557 |
269 |
21 |
145 |
0 |
5 |
BP |
GO:0050896;response to stimulus |
GO:0009725;response to hormone
|
237 |
121 |
8 |
72 |
0 |
4 |
BP |
GO:0008152;metabolic process |
GO:0070213;protein auto-ADP-ribosylation
|
69 |
41 |
5 |
23 |
1 |
2 |
BP |
GO:0008152;metabolic process |
GO:0022900;electron transport chain
|
108 |
41 |
2 |
27 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0007210;serotonin receptor signaling pathway
|
112 |
60 |
10 |
35 |
0 |
5 |
BP |
GO:0009987;cellular process |
GO:0071880;adenylate cyclase-activating adrenergic receptor signaling pathway
|
46 |
28 |
5 |
12 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0007198;adenylate cyclase-inhibiting serotonin receptor signaling pathway
|
98 |
47 |
3 |
31 |
0 |
5 |
BP |
GO:0009987;cellular process |
GO:0002031;G-protein coupled receptor internalization
|
49 |
22 |
1 |
13 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0010513;positive regulation of phosphatidylinositol biosynthetic process
|
44 |
28 |
8 |
11 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0014059;regulation of dopamine secretion
|
43 |
16 |
2 |
10 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0007194;negative regulation of adenylate cyclase activity
|
45 |
21 |
2 |
13 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0070374;positive regulation of ERK1 and ERK2 cascade
|
293 |
162 |
16 |
91 |
0 |
7 |
BP |
GO:0051179;localization |
GO:0051209;release of sequestered calcium ion into cytosol
|
37 |
18 |
2 |
7 |
0 |
2 |
BP |
GO:0023052;signaling |
GO:0051967;negative regulation of synaptic transmission, glutamatergic
|
43 |
20 |
1 |
10 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0007208;phospholipase C-activating serotonin receptor signaling pathway
|
41 |
27 |
8 |
10 |
0 |
2 |
BP |
GO:0007610;behavior |
GO:0048148;behavioral response to cocaine
|
57 |
27 |
3 |
15 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0007202;activation of phospholipase C activity
|
23 |
9 |
2 |
4 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0032098;regulation of appetite
|
19 |
6 |
0 |
3 |
0 |
2 |
BP |
GO:0007610;behavior |
GO:0007626;locomotory behavior
|
32 |
14 |
0 |
9 |
0 |
3 |
BP |
GO:0065007;biological regulation |
GO:0002032;desensitization of G-protein coupled receptor protein signaling pathway by arrestin
|
19 |
7 |
1 |
3 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0060160;negative regulation of dopamine receptor signaling pathway
|
50 |
23 |
1 |
14 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0002025;norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure
|
20 |
8 |
2 |
3 |
0 |
2 |
BP |
GO:0007610;behavior |
GO:0042755;eating behavior
|
19 |
7 |
1 |
3 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0035625;epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway
|
214 |
102 |
10 |
52 |
0 |
3 |
BP |
GO:0065007;biological regulation |
GO:0001994;norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure
|
20 |
8 |
1 |
3 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0032811;negative regulation of epinephrine secretion
|
215 |
103 |
10 |
53 |
0 |
3 |
BP |
GO:0032501;multicellular organismal process |
GO:0014827;intestine smooth muscle contraction
|
24 |
11 |
0 |
5 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0043278;response to morphine
|
43 |
13 |
1 |
9 |
0 |
2 |
BP |
GO:0023052;signaling |
GO:0032228;regulation of synaptic transmission, GABAergic
|
34 |
21 |
2 |
12 |
0 |
2 |
BP |
Unclassified; |
GO:0045907;positive regulation of vasoconstriction
|
24 |
12 |
3 |
5 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0071312;cellular response to alkaloid
|
19 |
7 |
1 |
3 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0045987;positive regulation of smooth muscle contraction
|
19 |
7 |
1 |
3 |
0 |
2 |
BP |
GO:0040011;locomotion |
GO:0090325;regulation of locomotion involved in locomotory behavior
|
49 |
23 |
1 |
14 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0071502;cellular response to temperature stimulus
|
23 |
11 |
1 |
5 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0007190;activation of adenylate cyclase activity
|
34 |
12 |
2 |
9 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0050709;negative regulation of protein secretion
|
37 |
13 |
1 |
9 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0014062;regulation of serotonin secretion
|
22 |
9 |
1 |
4 |
0 |
2 |
BP |
GO:0007610;behavior |
GO:0008542;visual learning
|
68 |
35 |
2 |
18 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0038003;opioid receptor signaling pathway
|
21 |
7 |
0 |
3 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0031649;heat generation
|
20 |
8 |
2 |
3 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0010700;negative regulation of norepinephrine secretion
|
84 |
44 |
5 |
23 |
0 |
2 |
BP |
GO:0023052;signaling |
GO:0051584;regulation of dopamine uptake involved in synaptic transmission
|
56 |
29 |
2 |
13 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0032922;circadian regulation of gene expression
|
67 |
25 |
2 |
19 |
0 |
5 |
BP |
GO:0032501;multicellular organismal process |
GO:0002024;diet induced thermogenesis
|
19 |
7 |
2 |
3 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0007191;adenylate cyclase-activating dopamine receptor signaling pathway
|
39 |
15 |
0 |
11 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0007195;adenylate cyclase-inhibiting dopamine receptor signaling pathway
|
45 |
19 |
1 |
12 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0034776;response to histamine
|
44 |
19 |
1 |
12 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0040015;negative regulation of multicellular organism growth
|
17 |
6 |
2 |
2 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0043401;steroid hormone mediated signaling pathway
|
207 |
101 |
5 |
64 |
1 |
4 |
BP |
GO:0008152;metabolic process |
GO:0006367;transcription initiation from RNA polymerase II promoter
|
209 |
111 |
9 |
69 |
1 |
4 |
BP |
GO:0009987;cellular process |
GO:0030522;intracellular receptor signaling pathway
|
252 |
123 |
9 |
78 |
1 |
5 |
BP |
Unclassified; |
GO:0044259;multicellular organismal macromolecule metabolic process
|
193 |
120 |
15 |
64 |
0 |
5 |
BP |
Unclassified; |
GO:0044236;multicellular organism metabolic process
|
190 |
117 |
14 |
62 |
0 |
6 |
BP |
GO:0008152;metabolic process |
GO:0030574;collagen catabolic process
|
172 |
103 |
10 |
55 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0022617;extracellular matrix disassembly
|
146 |
84 |
7 |
45 |
0 |
3 |
BP |
GO:0032502;developmental process |
GO:0048513;animal organ development
|
130 |
62 |
5 |
35 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0051289;protein homotetramerization
|
17 |
11 |
2 |
6 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0010035;response to inorganic substance
|
349 |
158 |
8 |
94 |
0 |
11 |
BP |
GO:0009987;cellular process |
GO:0001973;adenosine receptor signaling pathway
|
224 |
134 |
10 |
78 |
0 |
4 |
BP |
GO:0050896;response to stimulus |
GO:0001666;response to hypoxia
|
296 |
174 |
18 |
108 |
0 |
11 |
BP |
GO:0008283;cell proliferation |
GO:0008285;negative regulation of cell proliferation
|
79 |
41 |
1 |
21 |
0 |
3 |
BP |
GO:0023052;signaling |
GO:0032230;positive regulation of synaptic transmission, GABAergic
|
264 |
121 |
9 |
74 |
0 |
4 |
BP |
GO:0065007;biological regulation |
GO:0048878;chemical homeostasis
|
335 |
162 |
10 |
94 |
1 |
9 |
BP |
GO:0050896;response to stimulus |
GO:0071498;cellular response to fluid shear stress
|
21 |
13 |
2 |
6 |
0 |
1 |
BP |
GO:0023052;signaling |
GO:0051968;positive regulation of synaptic transmission, glutamatergic
|
19 |
11 |
0 |
7 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0017144;drug metabolic process
|
163 |
84 |
6 |
57 |
0 |
6 |
BP |
GO:0050896;response to stimulus |
GO:0014074;response to purine-containing compound
|
37 |
20 |
1 |
12 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0035295;tube development
|
17 |
9 |
0 |
5 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0043114;regulation of vascular permeability
|
21 |
13 |
1 |
7 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
20 |
12 |
0 |
7 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0050728;negative regulation of inflammatory response
|
308 |
156 |
15 |
97 |
0 |
7 |
BP |
GO:0009987;cellular process |
GO:0007569;cell aging
|
32 |
15 |
1 |
10 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0014070;response to organic cyclic compound
|
549 |
252 |
19 |
151 |
0 |
9 |
BP |
GO:0051179;localization |
GO:0051050;positive regulation of transport
|
45 |
27 |
3 |
14 |
0 |
3 |
BP |
GO:0050896;response to stimulus |
GO:0010039;response to iron ion
|
27 |
14 |
1 |
12 |
0 |
2 |
BP |
GO:0008283;cell proliferation |
GO:2000648;positive regulation of stem cell proliferation
|
18 |
8 |
0 |
8 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0032787;monocarboxylic acid metabolic process
|
89 |
43 |
2 |
30 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:0071456;cellular response to hypoxia
|
134 |
66 |
5 |
41 |
0 |
6 |
BP |
Unclassified; |
GO:0042310;vasoconstriction
|
82 |
44 |
7 |
28 |
0 |
3 |
BP |
GO:0032501;multicellular organismal process |
GO:0001659;temperature homeostasis
|
20 |
7 |
1 |
7 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0097746;regulation of blood vessel diameter
|
94 |
55 |
8 |
31 |
0 |
3 |
BP |
GO:0050896;response to stimulus |
GO:0009628;response to abiotic stimulus
|
58 |
26 |
2 |
14 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0021853;cerebral cortex GABAergic interneuron migration
|
58 |
34 |
1 |
20 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0050795;regulation of behavior
|
16 |
14 |
5 |
6 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0030432;peristalsis
|
34 |
16 |
0 |
11 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0018958;phenol-containing compound metabolic process
|
12 |
8 |
0 |
5 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0021756;striatum development
|
32 |
14 |
0 |
10 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0045597;positive regulation of cell differentiation
|
6 |
5 |
1 |
3 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0007625;grooming behavior
|
30 |
13 |
0 |
10 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071407;cellular response to organic cyclic compound
|
478 |
241 |
26 |
138 |
0 |
13 |
BP |
GO:0008152;metabolic process |
GO:0072593;reactive oxygen species metabolic process
|
74 |
37 |
2 |
26 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0001961;positive regulation of cytokine-mediated signaling pathway
|
128 |
66 |
8 |
42 |
0 |
4 |
BP |
GO:0008152;metabolic process |
GO:0050665;hydrogen peroxide biosynthetic process
|
442 |
181 |
9 |
126 |
1 |
4 |
BP |
GO:0009987;cellular process |
GO:0048010;vascular endothelial growth factor receptor signaling pathway
|
132 |
66 |
9 |
36 |
0 |
2 |
BP |
GO:0022610;biological adhesion |
GO:0051893;regulation of focal adhesion assembly
|
32 |
12 |
1 |
4 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0007172;signal complex assembly
|
32 |
12 |
1 |
4 |
0 |
1 |
BP |
GO:0002376;immune system process |
GO:0002684;positive regulation of immune system process
|
39 |
17 |
1 |
10 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0060159;regulation of dopamine receptor signaling pathway
|
32 |
12 |
1 |
4 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0038127;ERBB signaling pathway
|
32 |
12 |
1 |
4 |
0 |
1 |
BP |
GO:0032502;developmental process |
GO:0048608;reproductive structure development
|
33 |
13 |
2 |
4 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0045595;regulation of cell differentiation
|
31 |
10 |
1 |
4 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0038166;angiotensin-activated signaling pathway
|
32 |
12 |
1 |
4 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0014066;regulation of phosphatidylinositol 3-kinase signaling
|
41 |
21 |
3 |
8 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0030168;platelet activation
|
58 |
30 |
6 |
16 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:2000811;negative regulation of anoikis
|
37 |
16 |
2 |
5 |
0 |
1 |
BP |
GO:0051179;localization |
GO:2000641;regulation of early endosome to late endosome transport
|
32 |
11 |
1 |
4 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0071222;cellular response to lipopolysaccharide
|
38 |
12 |
1 |
5 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0044597;daunorubicin metabolic process
|
58 |
32 |
2 |
15 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0044598;doxorubicin metabolic process
|
60 |
29 |
2 |
12 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0032355;response to estradiol
|
60 |
23 |
2 |
12 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016125;sterol metabolic process
|
26 |
9 |
0 |
8 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0009820;alkaloid metabolic process
|
246 |
112 |
7 |
59 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0009804;coumarin metabolic process
|
125 |
58 |
3 |
38 |
1 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0032496;response to lipopolysaccharide
|
270 |
121 |
10 |
70 |
0 |
4 |
BP |
GO:0050896;response to stimulus |
GO:0010243;response to organonitrogen compound
|
57 |
34 |
2 |
21 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902533;positive regulation of intracellular signal transduction
|
68 |
38 |
0 |
25 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0038171;cannabinoid signaling pathway
|
124 |
55 |
3 |
38 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0045471;response to ethanol
|
80 |
33 |
3 |
25 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0051262;protein tetramerization
|
47 |
27 |
5 |
16 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0051001;negative regulation of nitric-oxide synthase activity
|
103 |
41 |
3 |
27 |
0 |
1 |
BP |
GO:0019740;nitrogen utilization |
GO:0006808;regulation of nitrogen utilization
|
107 |
52 |
6 |
26 |
0 |
5 |
BP |
GO:0009987;cellular process |
GO:0051716;cellular response to stimulus
|
36 |
20 |
1 |
13 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:1901653;cellular response to peptide
|
170 |
84 |
4 |
51 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0002933;lipid hydroxylation
|
209 |
93 |
6 |
56 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0006954;inflammatory response
|
79 |
41 |
4 |
23 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0055082;cellular chemical homeostasis
|
73 |
34 |
6 |
18 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0014065;phosphatidylinositol 3-kinase signaling
|
92 |
47 |
6 |
28 |
0 |
1 |
BP |
GO:0040007;growth |
GO:0045927;positive regulation of growth
|
90 |
47 |
6 |
30 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0051495;positive regulation of cytoskeleton organization
|
90 |
50 |
3 |
31 |
0 |
2 |
BP |
GO:0022610;biological adhesion |
GO:0034446;substrate adhesion-dependent cell spreading
|
74 |
36 |
0 |
22 |
0 |
1 |
BP |
GO:0008283;cell proliferation |
GO:0042127;regulation of cell proliferation
|
129 |
66 |
2 |
42 |
0 |
4 |
BP |
GO:0008152;metabolic process |
GO:0006082;organic acid metabolic process
|
11 |
4 |
0 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010557;positive regulation of macromolecule biosynthetic process
|
52 |
29 |
5 |
13 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0031328;positive regulation of cellular biosynthetic process
|
19 |
16 |
4 |
5 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0006508;proteolysis
|
4 |
3 |
2 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071417;cellular response to organonitrogen compound
|
95 |
69 |
15 |
31 |
0 |
7 |
BP |
GO:0008152;metabolic process |
GO:0006805;xenobiotic metabolic process
|
273 |
142 |
13 |
73 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0019752;carboxylic acid metabolic process
|
7 |
6 |
2 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2000107;negative regulation of leukocyte apoptotic process
|
42 |
16 |
3 |
9 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:2001303;lipoxin A4 biosynthetic process
|
262 |
161 |
20 |
97 |
0 |
9 |
BP |
GO:0008152;metabolic process |
GO:0051122;hepoxilin biosynthetic process
|
218 |
138 |
18 |
79 |
0 |
6 |
BP |
GO:0009987;cellular process |
GO:1902751;positive regulation of cell cycle G2/M phase transition
|
8 |
7 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051090;regulation of DNA binding transcription factor activity
|
16 |
9 |
1 |
7 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0010575;positive regulation of vascular endothelial growth factor production
|
28 |
18 |
3 |
9 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0055093;response to hyperoxia
|
81 |
60 |
11 |
36 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0071345;cellular response to cytokine stimulus
|
19 |
15 |
4 |
7 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:1901992;positive regulation of mitotic cell cycle phase transition
|
30 |
13 |
0 |
11 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:2000045;regulation of G1/S transition of mitotic cell cycle
|
6 |
4 |
2 |
2 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0071276;cellular response to cadmium ion
|
78 |
51 |
8 |
29 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0030641;regulation of cellular pH
|
15 |
8 |
2 |
3 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0032148;activation of protein kinase B activity
|
29 |
24 |
4 |
10 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0008202;steroid metabolic process
|
632 |
271 |
24 |
166 |
0 |
7 |
BP |
GO:0022414;reproductive process |
GO:0001892;embryonic placenta development
|
47 |
21 |
2 |
10 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0009314;response to radiation
|
38 |
16 |
5 |
9 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:1903580;positive regulation of ATP metabolic process
|
73 |
35 |
3 |
24 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0009967;positive regulation of signal transduction
|
69 |
32 |
1 |
20 |
1 |
2 |
BP |
GO:0009987;cellular process |
GO:0033554;cellular response to stress
|
123 |
57 |
6 |
30 |
0 |
6 |
BP |
GO:0050896;response to stimulus |
GO:0042493;response to drug
|
102 |
42 |
3 |
24 |
0 |
3 |
BP |
GO:0008152;metabolic process |
GO:0006706;steroid catabolic process
|
169 |
77 |
3 |
48 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0008209;androgen metabolic process
|
92 |
41 |
3 |
27 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0097695;establishment of macromolecular complex localization to telomere
|
3 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0097694;establishment of RNA localization to telomere
|
3 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0071840;cellular component organization or biogenesis |
GO:1904884;positive regulation of telomerase catalytic core complex assembly
|
4 |
4 |
1 |
2 |
0 |
0 |
BP |
Unclassified; |
GO:0035428;hexose transmembrane transport
|
51 |
23 |
4 |
12 |
0 |
1 |
BP |
GO:0051179;localization |
GO:1904659;glucose transmembrane transport
|
51 |
23 |
4 |
12 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0051054;positive regulation of DNA metabolic process
|
29 |
12 |
0 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:1902893;regulation of pri-miRNA transcription from RNA polymerase II promoter
|
55 |
32 |
3 |
24 |
1 |
4 |
BP |
GO:0050896;response to stimulus |
GO:1901652;response to peptide
|
32 |
21 |
6 |
8 |
1 |
4 |
BP |
GO:0009987;cellular process |
GO:0010638;positive regulation of organelle organization
|
52 |
31 |
4 |
15 |
1 |
4 |
BP |
GO:0008152;metabolic process |
GO:2000377;regulation of reactive oxygen species metabolic process
|
46 |
30 |
3 |
11 |
1 |
2 |
BP |
GO:0065007;biological regulation |
GO:0042592;homeostatic process
|
134 |
66 |
4 |
34 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0030198;extracellular matrix organization
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0030260;entry into host cell
|
5 |
4 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019433;triglyceride catabolic process
|
324 |
182 |
28 |
105 |
0 |
9 |
BP |
GO:0051179;localization |
GO:0006909;phagocytosis
|
18 |
12 |
3 |
8 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0006950;response to stress
|
21 |
12 |
1 |
6 |
0 |
0 |
BP |
GO:0048511;rhythmic process |
GO:0042752;regulation of circadian rhythm
|
34 |
17 |
1 |
10 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0034599;cellular response to oxidative stress
|
26 |
12 |
0 |
12 |
0 |
0 |
BP |
GO:0040011;locomotion |
GO:0030334;regulation of cell migration
|
69 |
30 |
1 |
25 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0019372;lipoxygenase pathway
|
108 |
64 |
7 |
39 |
0 |
3 |
BP |
GO:0065007;biological regulation |
GO:0043393;regulation of protein binding
|
12 |
9 |
1 |
4 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0032870;cellular response to hormone stimulus
|
36 |
16 |
1 |
9 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0010907;positive regulation of glucose metabolic process
|
56 |
28 |
3 |
23 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0001775;cell activation
|
3 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0045744;negative regulation of G-protein coupled receptor protein signaling pathway
|
6 |
6 |
2 |
4 |
0 |
0 |
BP |
Unclassified; |
GO:0019229;regulation of vasoconstriction
|
9 |
9 |
2 |
3 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0044070;regulation of anion transport
|
21 |
6 |
0 |
3 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0006939;smooth muscle contraction
|
38 |
17 |
0 |
13 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0016488;farnesol catabolic process
|
12 |
5 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001252;positive regulation of chromosome organization
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0007610;behavior
|
31 |
16 |
1 |
13 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0090068;positive regulation of cell cycle process
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0070989;oxidative demethylation
|
431 |
196 |
13 |
112 |
0 |
3 |
BP |
GO:0008283;cell proliferation |
GO:0008283;cell proliferation
|
36 |
17 |
3 |
9 |
0 |
2 |
BP |
GO:0008283;cell proliferation |
GO:1904707;positive regulation of vascular smooth muscle cell proliferation
|
58 |
45 |
12 |
24 |
0 |
3 |
BP |
GO:0050896;response to stimulus |
GO:0071375;cellular response to peptide hormone stimulus
|
41 |
18 |
5 |
11 |
0 |
0 |
BP |
GO:0000003;reproduction |
GO:0022414;reproductive process
|
7 |
6 |
2 |
5 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0001503;ossification
|
25 |
24 |
8 |
11 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0010634;positive regulation of epithelial cell migration
|
9 |
7 |
2 |
6 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0023057;negative regulation of signaling
|
4 |
4 |
1 |
2 |
0 |
1 |
BP |
GO:0032502;developmental process |
GO:0009888;tissue development
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0051222;positive regulation of protein transport
|
26 |
15 |
0 |
9 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0071073;positive regulation of phospholipid biosynthetic process
|
49 |
18 |
1 |
10 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0018105;peptidyl-serine phosphorylation
|
46 |
20 |
0 |
15 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0018107;peptidyl-threonine phosphorylation
|
13 |
8 |
1 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043065;positive regulation of apoptotic process
|
32 |
19 |
2 |
11 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0048731;system development
|
4 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0007498;mesoderm development
|
6 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0000186;activation of MAPKK activity
|
6 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0048015;phosphatidylinositol-mediated signaling
|
6 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010468;regulation of gene expression
|
5 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0080135;regulation of cellular response to stress
|
27 |
10 |
0 |
4 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0000187;activation of MAPK activity
|
11 |
6 |
0 |
5 |
0 |
0 |
BP |
Unclassified; |
GO:0007262;STAT protein import into nucleus
|
6 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0022610;biological adhesion |
GO:0045785;positive regulation of cell adhesion
|
5 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0002066;columnar/cuboidal epithelial cell development
|
4 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0010975;regulation of neuron projection development
|
4 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1904885;beta-catenin destruction complex assembly
|
6 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010543;regulation of platelet activation
|
4 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0010863;positive regulation of phospholipase C activity
|
7 |
4 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0097194;execution phase of apoptosis
|
52 |
18 |
0 |
16 |
0 |
1 |
BP |
GO:0022610;biological adhesion |
GO:0001952;regulation of cell-matrix adhesion
|
5 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902531;regulation of intracellular signal transduction
|
9 |
8 |
1 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046885;regulation of hormone biosynthetic process
|
11 |
4 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0061370;testosterone biosynthetic process
|
46 |
15 |
1 |
10 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0038084;vascular endothelial growth factor signaling pathway
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress
|
3 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060068;vagina development
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0033160;positive regulation of protein import into nucleus, translocation
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002522;leukocyte migration involved in immune response
|
9 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001028;positive regulation of endothelial cell chemotaxis
|
10 |
6 |
0 |
3 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0034097;response to cytokine
|
28 |
14 |
0 |
7 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051900;regulation of mitochondrial depolarization
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0033138;positive regulation of peptidyl-serine phosphorylation
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046854;phosphatidylinositol phosphorylation
|
6 |
5 |
0 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010508;positive regulation of autophagy
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0070640;vitamin D3 metabolic process
|
3 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0014042;positive regulation of neuron maturation
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0046620;regulation of organ growth
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0001818;negative regulation of cytokine production
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0045088;regulation of innate immune response
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001235;positive regulation of apoptotic signaling pathway
|
8 |
1 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0051726;regulation of cell cycle
|
17 |
5 |
0 |
3 |
0 |
0 |
BP |
Unclassified; |
GO:0097062;dendritic spine maintenance
|
71 |
31 |
1 |
16 |
0 |
0 |
BP |
Unclassified; |
GO:0035413;positive regulation of catenin import into nucleus
|
39 |
17 |
1 |
7 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0097242;amyloid-beta clearance
|
39 |
17 |
1 |
7 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006629;lipid metabolic process
|
40 |
11 |
0 |
10 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0016042;lipid catabolic process
|
69 |
34 |
1 |
28 |
0 |
1 |
BP |
GO:0032502;developmental process |
GO:0048856;anatomical structure development
|
58 |
32 |
2 |
22 |
0 |
1 |
BP |
GO:0002376;immune system process |
GO:0010760;negative regulation of macrophage chemotaxis
|
50 |
18 |
0 |
15 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0035162;embryonic hemopoiesis
|
6 |
5 |
3 |
2 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0030154;cell differentiation
|
14 |
14 |
5 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0032963;collagen metabolic process
|
12 |
10 |
5 |
5 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0033273;response to vitamin
|
26 |
23 |
7 |
11 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0007346;regulation of mitotic cell cycle
|
46 |
23 |
1 |
14 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0050714;positive regulation of protein secretion
|
58 |
38 |
5 |
30 |
0 |
3 |
BP |
GO:0032502;developmental process |
GO:0048732;gland development
|
17 |
11 |
1 |
6 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0001819;positive regulation of cytokine production
|
10 |
10 |
2 |
7 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902905;positive regulation of supramolecular fiber organization
|
35 |
17 |
2 |
12 |
0 |
2 |
BP |
GO:0008283;cell proliferation |
GO:0050679;positive regulation of epithelial cell proliferation
|
38 |
22 |
1 |
18 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway
|
14 |
13 |
5 |
6 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0048871;multicellular organismal homeostasis
|
18 |
8 |
1 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0030258;lipid modification
|
22 |
11 |
2 |
6 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0031334;positive regulation of protein complex assembly
|
24 |
12 |
2 |
7 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0046486;glycerolipid metabolic process
|
4 |
3 |
1 |
2 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0035635;entry of bacterium into host cell
|
20 |
10 |
0 |
6 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0007197;adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway
|
29 |
24 |
5 |
8 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0007207;phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway
|
29 |
24 |
5 |
8 |
0 |
1 |
BP |
GO:0023052;signaling |
GO:0007271;synaptic transmission, cholinergic
|
32 |
27 |
6 |
8 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0007399;nervous system development
|
28 |
19 |
2 |
10 |
0 |
0 |
BP |
GO:0040011;locomotion |
GO:0040012;regulation of locomotion
|
3 |
2 |
0 |
2 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0051930;regulation of sensory perception of pain
|
35 |
14 |
2 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0043270;positive regulation of ion transport
|
12 |
8 |
1 |
6 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0045893;positive regulation of transcription, DNA-templated
|
39 |
22 |
2 |
17 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0030520;intracellular estrogen receptor signaling pathway
|
37 |
21 |
1 |
17 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:1901796;regulation of signal transduction by p53 class mediator
|
44 |
22 |
3 |
18 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0016101;diterpenoid metabolic process
|
57 |
24 |
1 |
23 |
0 |
2 |
BP |
GO:0051179;localization |
GO:0060341;regulation of cellular localization
|
49 |
23 |
1 |
19 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0006807;nitrogen compound metabolic process
|
10 |
6 |
0 |
1 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:1904355;positive regulation of telomere capping
|
11 |
9 |
2 |
5 |
0 |
1 |
BP |
GO:0008283;cell proliferation |
GO:0002052;positive regulation of neuroblast proliferation
|
5 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0032212;positive regulation of telomere maintenance via telomerase
|
7 |
6 |
1 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019858;cytosine metabolic process
|
8 |
5 |
1 |
3 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0007228;positive regulation of hh target transcription factor activity
|
4 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0003140;determination of left/right asymmetry in lateral mesoderm
|
4 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0021938;smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation
|
36 |
10 |
1 |
11 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0040014;regulation of multicellular organism growth
|
3 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051100;negative regulation of binding
|
3 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0042149;cellular response to glucose starvation
|
20 |
5 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016241;regulation of macroautophagy
|
17 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0044281;small molecule metabolic process
|
16 |
11 |
1 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0019725;cellular homeostasis
|
4 |
4 |
1 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0045859;regulation of protein kinase activity
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0070542;response to fatty acid
|
113 |
55 |
5 |
32 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0043434;response to peptide hormone
|
44 |
22 |
3 |
11 |
0 |
1 |
BP |
Unclassified; |
GO:1990535;neuron projection maintenance
|
28 |
11 |
0 |
9 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0031663;lipopolysaccharide-mediated signaling pathway
|
5 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:0060045;positive regulation of cardiac muscle cell proliferation
|
34 |
9 |
1 |
11 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0034605;cellular response to heat
|
32 |
14 |
0 |
5 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0034162;toll-like receptor 9 signaling pathway
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002758;innate immune response-activating signal transduction
|
10 |
5 |
0 |
3 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0032088;negative regulation of NF-kappaB transcription factor activity
|
3 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071480;cellular response to gamma radiation
|
3 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0050727;regulation of inflammatory response
|
20 |
8 |
0 |
8 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070372;regulation of ERK1 and ERK2 cascade
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0097028;dendritic cell differentiation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0040011;locomotion |
GO:0050920;regulation of chemotaxis
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0038128;ERBB2 signaling pathway
|
6 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071364;cellular response to epidermal growth factor stimulus
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0000226;microtubule cytoskeleton organization
|
4 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0034641;cellular nitrogen compound metabolic process
|
6 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:0001938;positive regulation of endothelial cell proliferation
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016572;histone phosphorylation
|
37 |
16 |
2 |
8 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:2000379;positive regulation of reactive oxygen species metabolic process
|
31 |
14 |
1 |
6 |
0 |
1 |
BP |
GO:0040011;locomotion |
GO:0001667;ameboidal-type cell migration
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0009887;animal organ morphogenesis
|
12 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070228;regulation of lymphocyte apoptotic process
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0035235;ionotropic glutamate receptor signaling pathway
|
36 |
23 |
3 |
15 |
0 |
1 |
BP |
GO:0023052;signaling |
GO:0060079;excitatory postsynaptic potential
|
40 |
27 |
3 |
16 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0007196;adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway
|
19 |
14 |
3 |
9 |
0 |
1 |
BP |
GO:0023052;signaling |
GO:0051966;regulation of synaptic transmission, glutamatergic
|
16 |
12 |
2 |
8 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0010038;response to metal ion
|
84 |
43 |
5 |
25 |
0 |
1 |
BP |
GO:0022414;reproductive process |
GO:0007566;embryo implantation
|
10 |
8 |
0 |
4 |
0 |
1 |
BP |
Unclassified; |
GO:0003056;regulation of vascular smooth muscle contraction
|
20 |
15 |
3 |
5 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0050805;negative regulation of synaptic transmission
|
38 |
22 |
1 |
10 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0046541;saliva secretion
|
26 |
21 |
4 |
6 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0009115;xanthine catabolic process
|
16 |
6 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0035239;tube morphogenesis
|
7 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:2000194;regulation of female gonad development
|
7 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0046628;positive regulation of insulin receptor signaling pathway
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010564;regulation of cell cycle process
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1901989;positive regulation of cell cycle phase transition
|
8 |
8 |
3 |
4 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:1902895;positive regulation of pri-miRNA transcription from RNA polymerase II promoter
|
24 |
10 |
3 |
7 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0043457;regulation of cellular respiration
|
5 |
5 |
3 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0033280;response to vitamin D
|
4 |
4 |
2 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0060134;prepulse inhibition
|
37 |
18 |
0 |
15 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0001975;response to amphetamine
|
35 |
19 |
1 |
13 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0035815;positive regulation of renal sodium excretion
|
24 |
10 |
0 |
8 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0030817;regulation of cAMP biosynthetic process
|
5 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0043266;regulation of potassium ion transport
|
5 |
3 |
2 |
1 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0046883;regulation of hormone secretion
|
8 |
5 |
1 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0042321;negative regulation of circadian sleep/wake cycle, sleep
|
4 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0045776;negative regulation of blood pressure
|
26 |
11 |
0 |
9 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0043271;negative regulation of ion transport
|
3 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0048167;regulation of synaptic plasticity
|
9 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019216;regulation of lipid metabolic process
|
8 |
5 |
1 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0007416;synapse assembly
|
14 |
10 |
0 |
5 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0060158;phospholipase C-activating dopamine receptor signaling pathway
|
28 |
12 |
0 |
10 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0035810;positive regulation of urine volume
|
3 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0014048;regulation of glutamate secretion
|
4 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009636;response to toxic substance
|
67 |
27 |
4 |
13 |
0 |
3 |
BP |
GO:0050896;response to stimulus |
GO:0046677;response to antibiotic
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0023051;regulation of signaling
|
15 |
9 |
1 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0009822;alkaloid catabolic process
|
261 |
134 |
10 |
66 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0045761;regulation of adenylate cyclase activity
|
37 |
17 |
4 |
11 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0034220;ion transmembrane transport
|
19 |
11 |
0 |
6 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0044242;cellular lipid catabolic process
|
4 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0048143;astrocyte activation
|
50 |
19 |
0 |
19 |
0 |
4 |
BP |
GO:0023052;signaling |
GO:0046887;positive regulation of hormone secretion
|
10 |
9 |
1 |
8 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002682;regulation of immune system process
|
4 |
4 |
1 |
3 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0042060;wound healing
|
78 |
46 |
8 |
24 |
0 |
3 |
BP |
GO:0002376;immune system process |
GO:0045639;positive regulation of myeloid cell differentiation
|
3 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0030518;intracellular steroid hormone receptor signaling pathway
|
13 |
7 |
0 |
6 |
0 |
0 |
BP |
GO:0022414;reproductive process |
GO:0060748;tertiary branching involved in mammary gland duct morphogenesis
|
14 |
7 |
1 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019369;arachidonic acid metabolic process
|
67 |
36 |
4 |
17 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0006691;leukotriene metabolic process
|
62 |
36 |
1 |
24 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0031116;positive regulation of microtubule polymerization
|
36 |
11 |
1 |
13 |
0 |
3 |
BP |
GO:0050896;response to stimulus |
GO:0046688;response to copper ion
|
8 |
7 |
0 |
6 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0009653;anatomical structure morphogenesis
|
3 |
2 |
1 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019222;regulation of metabolic process
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006915;apoptotic process
|
6 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0040011;locomotion |
GO:0014910;regulation of smooth muscle cell migration
|
20 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:1903409;reactive oxygen species biosynthetic process
|
10 |
4 |
1 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009266;response to temperature stimulus
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0045600;positive regulation of fat cell differentiation
|
31 |
15 |
4 |
6 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0015721;bile acid and bile salt transport
|
102 |
37 |
2 |
32 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071280;cellular response to copper ion
|
30 |
9 |
0 |
11 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0002793;positive regulation of peptide secretion
|
13 |
4 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0000023;maltose metabolic process
|
35 |
14 |
1 |
11 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071320;cellular response to cAMP
|
5 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071396;cellular response to lipid
|
5 |
5 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0000122;negative regulation of transcription from RNA polymerase II promoter
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0043433;negative regulation of DNA binding transcription factor activity
|
4 |
2 |
1 |
2 |
0 |
1 |
BP |
GO:0023052;signaling |
GO:0090277;positive regulation of peptide hormone secretion
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0070198;protein localization to chromosome, telomeric region
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0010332;response to gamma radiation
|
18 |
10 |
2 |
8 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0010033;response to organic substance
|
20 |
12 |
0 |
8 |
0 |
2 |
BP |
GO:0032502;developmental process |
GO:0031214;biomineral tissue development
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0035408;histone H3-T6 phosphorylation
|
11 |
7 |
0 |
7 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0034351;negative regulation of glial cell apoptotic process
|
8 |
4 |
0 |
4 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0043627;response to estrogen
|
11 |
6 |
1 |
3 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0016579;protein deubiquitination
|
25 |
15 |
2 |
6 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042743;hydrogen peroxide metabolic process
|
2 |
2 |
1 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046456;icosanoid biosynthetic process
|
32 |
17 |
2 |
7 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0050878;regulation of body fluid levels
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0007613;memory
|
35 |
11 |
1 |
11 |
0 |
3 |
BP |
GO:0032501;multicellular organismal process |
GO:0001889;liver development
|
20 |
6 |
0 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0045787;positive regulation of cell cycle
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015711;organic anion transport
|
37 |
16 |
1 |
9 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0045931;positive regulation of mitotic cell cycle
|
44 |
20 |
2 |
15 |
0 |
3 |
BP |
GO:0008283;cell proliferation |
GO:0048146;positive regulation of fibroblast proliferation
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0042981;regulation of apoptotic process
|
9 |
4 |
0 |
3 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0043697;cell dedifferentiation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071392;cellular response to estradiol stimulus
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0048149;behavioral response to ethanol
|
19 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0003014;renal system process
|
6 |
3 |
1 |
3 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0071383;cellular response to steroid hormone stimulus
|
39 |
12 |
1 |
14 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:0038194;thyroid-stimulating hormone signaling pathway
|
57 |
17 |
1 |
20 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010894;negative regulation of steroid biosynthetic process
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0038183;bile acid signaling pathway
|
472 |
205 |
6 |
122 |
0 |
11 |
BP |
Unclassified; |
GO:1904504;positive regulation of lipophagy
|
7 |
4 |
0 |
3 |
0 |
1 |
BP |
GO:0051179;localization |
GO:2001257;regulation of cation channel activity
|
1 |
1 |
0 |
0 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0042572;retinol metabolic process
|
12 |
4 |
0 |
3 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0019228;neuronal action potential
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0086010;membrane depolarization during action potential
|
3 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0035725;sodium ion transmembrane transport
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0034765;regulation of ion transmembrane transport
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0048546;digestive tract morphogenesis
|
33 |
11 |
4 |
9 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0051000;positive regulation of nitric-oxide synthase activity
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0045821;positive regulation of glycolytic process
|
2 |
2 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:2000573;positive regulation of DNA biosynthetic process
|
8 |
8 |
3 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0051482;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway
|
2 |
1 |
1 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:0015758;glucose transport
|
29 |
11 |
2 |
7 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0032229;negative regulation of synaptic transmission, GABAergic
|
3 |
3 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0052652;cyclic purine nucleotide metabolic process
|
2 |
2 |
1 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0045986;negative regulation of smooth muscle contraction
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042135;neurotransmitter catabolic process
|
31 |
11 |
0 |
9 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0014063;negative regulation of serotonin secretion
|
30 |
10 |
0 |
9 |
0 |
2 |
BP |
GO:0032502;developmental process |
GO:0060065;uterus development
|
16 |
3 |
1 |
4 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0042180;cellular ketone metabolic process
|
4 |
4 |
1 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0001817;regulation of cytokine production
|
3 |
3 |
1 |
2 |
0 |
1 |
BP |
GO:0002376;immune system process |
GO:0045321;leukocyte activation
|
4 |
3 |
1 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071356;cellular response to tumor necrosis factor
|
2 |
2 |
1 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1900182;positive regulation of protein localization to nucleus
|
10 |
6 |
1 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006974;cellular response to DNA damage stimulus
|
9 |
6 |
1 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0055015;ventricular cardiac muscle cell development
|
20 |
6 |
2 |
5 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0006874;cellular calcium ion homeostasis
|
19 |
7 |
0 |
6 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0001662;behavioral fear response
|
14 |
4 |
0 |
4 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0099566;regulation of postsynaptic cytosolic calcium ion concentration
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015718;monocarboxylic acid transport
|
3 |
3 |
1 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0035094;response to nicotine
|
11 |
11 |
4 |
4 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0065009;regulation of molecular function
|
6 |
4 |
1 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0001932;regulation of protein phosphorylation
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0032909;regulation of transforming growth factor beta2 production
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042417;dopamine metabolic process
|
13 |
9 |
0 |
4 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0008217;regulation of blood pressure
|
28 |
14 |
0 |
8 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0051259;protein oligomerization
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0000733;DNA strand renaturation
|
48 |
19 |
1 |
14 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0044255;cellular lipid metabolic process
|
8 |
7 |
0 |
4 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0032094;response to food
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007095;mitotic G2 DNA damage checkpoint
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0001525;angiogenesis
|
4 |
4 |
1 |
3 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007249;I-kappaB kinase/NF-kappaB signaling
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0009968;negative regulation of signal transduction
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0021885;forebrain cell migration
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0032467;positive regulation of cytokinesis
|
17 |
4 |
0 |
6 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0014075;response to amine
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0046960;sensitization
|
16 |
7 |
0 |
7 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0060292;long term synaptic depression
|
14 |
5 |
0 |
6 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0019226;transmission of nerve impulse
|
13 |
4 |
0 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042053;regulation of dopamine metabolic process
|
16 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0045187;regulation of circadian sleep/wake cycle, sleep
|
18 |
6 |
0 |
7 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0007617;mating behavior
|
13 |
4 |
0 |
5 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0050482;arachidonic acid secretion
|
24 |
12 |
0 |
9 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0032880;regulation of protein localization
|
15 |
7 |
2 |
5 |
0 |
0 |
BP |
GO:0040007;growth |
GO:0040008;regulation of growth
|
11 |
6 |
1 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0035356;cellular triglyceride homeostasis
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0007628;adult walking behavior
|
51 |
16 |
1 |
18 |
0 |
4 |
BP |
GO:0050896;response to stimulus |
GO:2001025;positive regulation of response to drug
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0046903;secretion
|
7 |
4 |
2 |
0 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0045777;positive regulation of blood pressure
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0046888;negative regulation of hormone secretion
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0045741;positive regulation of epidermal growth factor-activated receptor activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0051896;regulation of protein kinase B signaling
|
11 |
2 |
0 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0033604;negative regulation of catecholamine secretion
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0009056;catabolic process
|
8 |
5 |
1 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071241;cellular response to inorganic substance
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0022414;reproductive process |
GO:0060745;mammary gland branching involved in pregnancy
|
5 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043524;negative regulation of neuron apoptotic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010821;regulation of mitochondrion organization
|
6 |
5 |
0 |
4 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0043085;positive regulation of catalytic activity
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0048013;ephrin receptor signaling pathway
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1901529;positive regulation of anion channel activity
|
6 |
3 |
1 |
1 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0034502;protein localization to chromosome
|
4 |
3 |
3 |
0 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0006855;drug transmembrane transport
|
13 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015872;dopamine transport
|
8 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015697;quaternary ammonium group transport
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007077;mitotic nuclear envelope disassembly
|
25 |
10 |
2 |
9 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0043279;response to alkaloid
|
42 |
11 |
1 |
9 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0072488;ammonium transmembrane transport
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0050996;positive regulation of lipid catabolic process
|
5 |
4 |
0 |
3 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015874;norepinephrine transport
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1901374;acetate ester transport
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0051051;negative regulation of transport
|
2 |
2 |
1 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071103;DNA conformation change
|
3 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0046618;drug export
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0038111;interleukin-7-mediated signaling pathway
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway
|
12 |
5 |
0 |
3 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0048639;positive regulation of developmental growth
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0032868;response to insulin
|
69 |
31 |
0 |
19 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0000902;cell morphogenesis
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0030098;lymphocyte differentiation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0022414;reproductive process |
GO:0048609;multicellular organismal reproductive process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043618;regulation of transcription from RNA polymerase II promoter in response to stress
|
5 |
4 |
0 |
4 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0051384;response to glucocorticoid
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0044774;mitotic DNA integrity checkpoint
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0007268;chemical synaptic transmission
|
6 |
4 |
0 |
3 |
0 |
0 |
BP |
GO:0048511;rhythmic process |
GO:0007623;circadian rhythm
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:2001023;regulation of response to drug
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009411;response to UV
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006004;fucose metabolic process
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019637;organophosphate metabolic process
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006081;cellular aldehyde metabolic process
|
3 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007188;adenylate cyclase-modulating G-protein coupled receptor signaling pathway
|
5 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0030003;cellular cation homeostasis
|
25 |
13 |
0 |
9 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0031324;negative regulation of cellular metabolic process
|
44 |
16 |
0 |
14 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0010906;regulation of glucose metabolic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0010891;negative regulation of sequestering of triglyceride
|
131 |
66 |
3 |
31 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0010887;negative regulation of cholesterol storage
|
120 |
60 |
3 |
30 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0010871;negative regulation of receptor biosynthetic process
|
118 |
60 |
3 |
30 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0019933;cAMP-mediated signaling
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0001997;positive regulation of the force of heart contraction by epinephrine-norepinephrine
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0001996;positive regulation of heart rate by epinephrine-norepinephrine
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0050873;brown fat cell differentiation
|
2 |
2 |
2 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0042596;fear response
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0042391;regulation of membrane potential
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0035095;behavioral response to nicotine
|
6 |
6 |
2 |
2 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0014832;urinary bladder smooth muscle contraction
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0001558;regulation of cell growth
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0051260;protein homooligomerization
|
2 |
1 |
1 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060523;prostate epithelial cord elongation
|
6 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060688;regulation of morphogenesis of a branching structure
|
3 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0033031;positive regulation of neutrophil apoptotic process
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0045833;negative regulation of lipid metabolic process
|
2 |
2 |
1 |
0 |
0 |
0 |
BP |
GO:0022610;biological adhesion |
GO:0030155;regulation of cell adhesion
|
3 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006260;DNA replication
|
12 |
7 |
0 |
5 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001038;regulation of cellular response to drug
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0006979;response to oxidative stress
|
9 |
5 |
0 |
5 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1903531;negative regulation of secretion by cell
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015908;fatty acid transport
|
169 |
82 |
4 |
46 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0051282;regulation of sequestering of calcium ion
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0090330;regulation of platelet aggregation
|
6 |
3 |
0 |
3 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0046627;negative regulation of insulin receptor signaling pathway
|
46 |
12 |
0 |
10 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0050861;positive regulation of B cell receptor signaling pathway
|
2 |
2 |
0 |
2 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0051973;positive regulation of telomerase activity
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006725;cellular aromatic compound metabolic process
|
13 |
8 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0032270;positive regulation of cellular protein metabolic process
|
11 |
5 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0045944;positive regulation of transcription from RNA polymerase II promoter
|
5 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0008360;regulation of cell shape
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0043304;regulation of mast cell degranulation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007258;JUN phosphorylation
|
9 |
1 |
0 |
3 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0000077;DNA damage checkpoint
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0046330;positive regulation of JNK cascade
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0070873;regulation of glycogen metabolic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0038095;Fc-epsilon receptor signaling pathway
|
16 |
2 |
0 |
3 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0045087;innate immune response
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010389;regulation of G2/M transition of mitotic cell cycle
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0048666;neuron development
|
8 |
1 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0043536;positive regulation of blood vessel endothelial cell migration
|
2 |
2 |
0 |
2 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0010518;positive regulation of phospholipase activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0032091;negative regulation of protein binding
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0089700;protein kinase D signaling
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:2001184;positive regulation of interleukin-12 secretion
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2000251;positive regulation of actin cytoskeleton reorganization
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0000185;activation of MAPKKK activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010628;positive regulation of gene expression
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0031023;microtubule organizing center organization
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0071840;cellular component organization or biogenesis |
GO:0044089;positive regulation of cellular component biogenesis
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0036006;cellular response to macrophage colony-stimulating factor stimulus
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0038033;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0051301;cell division
|
4 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0002076;osteoblast development
|
5 |
4 |
1 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0030878;thyroid gland development
|
4 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0031000;response to caffeine
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0006811;ion transport
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007093;mitotic cell cycle checkpoint
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0014038;regulation of Schwann cell differentiation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0097176;epoxide metabolic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1901386;negative regulation of voltage-gated calcium channel activity
|
17 |
4 |
0 |
5 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0051586;positive regulation of dopamine uptake involved in synaptic transmission
|
21 |
9 |
0 |
6 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0032415;regulation of sodium:proton antiporter activity
|
21 |
9 |
0 |
6 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0021984;adenohypophysis development
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0035404;histone-serine phosphorylation
|
14 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0019932;second-messenger-mediated signaling
|
2 |
2 |
1 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0090170;regulation of Golgi inheritance
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060440;trachea formation
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060020;Bergmann glial cell differentiation
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1903800;positive regulation of production of miRNAs involved in gene silencing by miRNA
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043410;positive regulation of MAPK cascade
|
21 |
12 |
1 |
6 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0043405;regulation of MAP kinase activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0001963;synaptic transmission, dopaminergic
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0050927;positive regulation of positive chemotaxis
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010641;positive regulation of platelet-derived growth factor receptor signaling pathway
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0007267;cell-cell signaling
|
3 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0033590;response to cobalamin
|
8 |
1 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:2000630;positive regulation of miRNA metabolic process
|
23 |
7 |
0 |
8 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0045075;regulation of interleukin-12 biosynthetic process
|
15 |
5 |
0 |
6 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071316;cellular response to nicotine
|
21 |
6 |
0 |
7 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902532;negative regulation of intracellular signal transduction
|
11 |
2 |
0 |
2 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0045646;regulation of erythrocyte differentiation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007254;JNK cascade
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0090400;stress-induced premature senescence
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0019896;axonal transport of mitochondrion
|
47 |
16 |
0 |
15 |
0 |
3 |
BP |
GO:0008152;metabolic process |
GO:0032930;positive regulation of superoxide anion generation
|
33 |
9 |
0 |
11 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis
|
3 |
2 |
0 |
1 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0051092;positive regulation of NF-kappaB transcription factor activity
|
10 |
3 |
0 |
3 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0042542;response to hydrogen peroxide
|
13 |
5 |
0 |
4 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0048545;response to steroid hormone
|
3 |
2 |
1 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0051926;negative regulation of calcium ion transport
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019371;cyclooxygenase pathway
|
14 |
6 |
0 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007200;phospholipase C-activating G-protein coupled receptor signaling pathway
|
3 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006198;cAMP catabolic process
|
4 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071479;cellular response to ionizing radiation
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002683;negative regulation of immune system process
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0001934;positive regulation of protein phosphorylation
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0043542;endothelial cell migration
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0031667;response to nutrient levels
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0022414;reproductive process |
GO:0060687;regulation of branching involved in prostate gland morphogenesis
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0097421;liver regeneration
|
30 |
8 |
2 |
8 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:2001237;negative regulation of extrinsic apoptotic signaling pathway
|
32 |
11 |
2 |
8 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0008210;estrogen metabolic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0032147;activation of protein kinase activity
|
9 |
5 |
0 |
3 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0007417;central nervous system development
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0051248;negative regulation of protein metabolic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0031635;adenylate cyclase-inhibiting opioid receptor signaling pathway
|
2 |
2 |
1 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071242;cellular response to ammonium ion
|
3 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0032769;negative regulation of monooxygenase activity
|
16 |
7 |
1 |
6 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0032956;regulation of actin cytoskeleton organization
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0050730;regulation of peptidyl-tyrosine phosphorylation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0061041;regulation of wound healing
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0043488;regulation of mRNA stability
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0019825;oxygen binding
|
2225 |
1050 |
82 |
626 |
1 |
38 |
MF |
GO:0003824;catalytic activity |
GO:0070330;aromatase activity
|
1941 |
923 |
74 |
541 |
1 |
37 |
MF |
GO:0005488;binding |
GO:0051879;Hsp90 protein binding
|
619 |
309 |
26 |
201 |
0 |
13 |
MF |
GO:0005488;binding |
GO:0005506;iron ion binding
|
1613 |
757 |
57 |
460 |
1 |
26 |
MF |
GO:0003824;catalytic activity |
GO:0004089;carbonate dehydratase activity
|
2724 |
1341 |
98 |
791 |
3 |
67 |
MF |
GO:0005488;binding |
GO:0020037;heme binding
|
1845 |
873 |
61 |
526 |
1 |
31 |
MF |
GO:0005488;binding |
GO:0005524;ATP binding
|
547 |
263 |
21 |
158 |
0 |
16 |
MF |
Unclassified; |
GO:0004716;signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
290 |
149 |
12 |
93 |
0 |
5 |
MF |
GO:0005488;binding |
GO:0044877;macromolecular complex binding
|
163 |
85 |
7 |
51 |
0 |
4 |
MF |
GO:0003824;catalytic activity |
GO:0016616;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
106 |
55 |
2 |
38 |
0 |
3 |
MF |
GO:0005488;binding |
GO:0019838;growth factor binding
|
220 |
119 |
9 |
79 |
0 |
4 |
MF |
GO:0104005;hijacked molecular function |
GO:0001618;virus receptor activity
|
218 |
100 |
7 |
72 |
0 |
6 |
MF |
GO:0005488;binding |
GO:0043548;phosphatidylinositol 3-kinase binding
|
172 |
94 |
9 |
63 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0043559;insulin binding
|
284 |
144 |
11 |
90 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0042562;hormone binding
|
248 |
137 |
11 |
91 |
0 |
5 |
MF |
GO:0060089;molecular transducer activity |
GO:0005021;vascular endothelial growth factor-activated receptor activity
|
545 |
242 |
8 |
150 |
0 |
10 |
MF |
GO:0060089;molecular transducer activity |
GO:0004714;transmembrane receptor protein tyrosine kinase activity
|
156 |
70 |
5 |
36 |
0 |
3 |
MF |
GO:0005488;binding |
GO:0005504;fatty acid binding
|
279 |
171 |
27 |
101 |
1 |
14 |
MF |
GO:0003824;catalytic activity |
GO:0008395;steroid hydroxylase activity
|
673 |
319 |
20 |
184 |
0 |
5 |
MF |
GO:0003824;catalytic activity |
GO:0003845;11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity
|
22 |
10 |
1 |
5 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0034875;caffeine oxidase activity
|
870 |
424 |
37 |
231 |
0 |
7 |
MF |
GO:0003824;catalytic activity |
GO:0009055;electron transfer activity
|
194 |
84 |
3 |
52 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0000166;nucleotide binding
|
95 |
43 |
2 |
20 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0009378;four-way junction helicase activity
|
129 |
63 |
3 |
42 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0051378;serotonin binding
|
113 |
61 |
10 |
35 |
0 |
5 |
MF |
GO:0060089;molecular transducer activity |
GO:0004993;G-protein coupled serotonin receptor activity
|
112 |
60 |
10 |
35 |
0 |
5 |
MF |
Unclassified; |
GO:0004872;receptor activity
|
456 |
236 |
29 |
144 |
0 |
12 |
MF |
GO:0005488;binding |
GO:0051379;epinephrine binding
|
193 |
91 |
9 |
52 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0051380;norepinephrine binding
|
26 |
14 |
4 |
7 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0071886;1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding
|
53 |
31 |
8 |
14 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0001965;G-protein alpha-subunit binding
|
18 |
6 |
0 |
3 |
0 |
2 |
MF |
GO:0060089;molecular transducer activity |
GO:0004937;alpha1-adrenergic receptor activity
|
20 |
8 |
1 |
3 |
0 |
2 |
MF |
GO:0060089;molecular transducer activity |
GO:0004938;alpha2-adrenergic receptor activity
|
298 |
136 |
13 |
70 |
0 |
7 |
MF |
GO:0060089;molecular transducer activity |
GO:0004939;beta-adrenergic receptor activity
|
20 |
8 |
2 |
3 |
0 |
2 |
MF |
GO:0060089;molecular transducer activity |
GO:0004985;opioid receptor activity
|
23 |
8 |
1 |
3 |
0 |
2 |
MF |
GO:0060089;molecular transducer activity |
GO:0001591;dopamine neurotransmitter receptor activity, coupled via Gi/Go
|
46 |
20 |
1 |
12 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0005496;steroid binding
|
351 |
173 |
13 |
111 |
1 |
7 |
MF |
GO:0060089;molecular transducer activity |
GO:0038052;RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
281 |
147 |
13 |
87 |
1 |
6 |
MF |
GO:0005488;binding |
GO:0034056;estrogen response element binding
|
240 |
129 |
13 |
75 |
1 |
5 |
MF |
GO:0098772;molecular function regulator |
GO:0030235;nitric-oxide synthase regulator activity
|
100 |
46 |
2 |
33 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0035174;histone serine kinase activity
|
71 |
27 |
2 |
13 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0008270;zinc ion binding
|
1402 |
705 |
61 |
411 |
2 |
34 |
MF |
GO:0003824;catalytic activity |
GO:0004222;metalloendopeptidase activity
|
90 |
42 |
3 |
25 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0017171;serine hydrolase activity
|
21 |
7 |
0 |
6 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0001609;G-protein coupled adenosine receptor activity
|
228 |
136 |
10 |
80 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0042802;identical protein binding
|
229 |
146 |
11 |
83 |
0 |
4 |
MF |
Unclassified; |
GO:0032403;protein complex binding
|
240 |
118 |
11 |
70 |
0 |
4 |
MF |
GO:0003824;catalytic activity |
GO:0004064;arylesterase activity
|
601 |
292 |
23 |
168 |
0 |
9 |
MF |
GO:0005488;binding |
GO:0046914;transition metal ion binding
|
132 |
61 |
2 |
39 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0031072;heat shock protein binding
|
49 |
32 |
0 |
19 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0032451;demethylase activity
|
186 |
81 |
1 |
57 |
0 |
4 |
MF |
GO:0060089;molecular transducer activity |
GO:0004952;dopamine neurotransmitter receptor activity
|
12 |
6 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0070576;vitamin D 24-hydroxylase activity
|
300 |
146 |
15 |
85 |
0 |
4 |
MF |
GO:0003824;catalytic activity |
GO:0101020;estrogen 16-alpha-hydroxylase activity
|
261 |
126 |
14 |
74 |
0 |
3 |
MF |
Unclassified; |
GO:0005057;signal transducer activity, downstream of receptor
|
30 |
10 |
1 |
4 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0005518;collagen binding
|
23 |
17 |
4 |
7 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0047750;cholestenol delta-isomerase activity
|
2 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0004949;cannabinoid receptor activity
|
146 |
59 |
3 |
41 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0043621;protein self-association
|
41 |
19 |
1 |
10 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0043560;insulin receptor substrate binding
|
130 |
63 |
7 |
35 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004666;prostaglandin-endoperoxide synthase activity
|
142 |
69 |
7 |
39 |
0 |
3 |
MF |
GO:0003824;catalytic activity |
GO:0047977;hepoxilin-epoxide hydrolase activity
|
288 |
177 |
22 |
110 |
0 |
12 |
MF |
GO:0003824;catalytic activity |
GO:0004052;arachidonate 12-lipoxygenase activity
|
273 |
169 |
22 |
101 |
0 |
11 |
MF |
GO:0003824;catalytic activity |
GO:0051120;hepoxilin A3 synthase activity
|
274 |
170 |
22 |
102 |
0 |
10 |
MF |
GO:0005215;transporter activity |
GO:0005412;glucose:sodium symporter activity
|
51 |
23 |
4 |
12 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0097371;MDM2/MDM4 family protein binding
|
44 |
26 |
3 |
14 |
1 |
2 |
MF |
GO:0003824;catalytic activity |
GO:0004712;protein serine/threonine/tyrosine kinase activity
|
40 |
13 |
1 |
8 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004713;protein tyrosine kinase activity
|
6 |
3 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004674;protein serine/threonine kinase activity
|
10 |
8 |
1 |
3 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0004879;nuclear receptor activity
|
247 |
121 |
10 |
69 |
0 |
4 |
MF |
GO:0060089;molecular transducer activity |
GO:0038023;signaling receptor activity
|
46 |
25 |
4 |
13 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0008144;drug binding
|
38 |
25 |
1 |
10 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0001223;transcription coactivator binding
|
28 |
17 |
6 |
7 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0046982;protein heterodimerization activity
|
17 |
13 |
4 |
8 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0003682;chromatin binding
|
42 |
15 |
4 |
10 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0042803;protein homodimerization activity
|
67 |
31 |
6 |
21 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0019902;phosphatase binding
|
41 |
26 |
4 |
10 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0031690;adrenergic receptor binding
|
84 |
43 |
5 |
27 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0045550;geranylgeranyl reductase activity
|
56 |
25 |
0 |
22 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0047718;indanol dehydrogenase activity
|
49 |
19 |
0 |
18 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0003690;double-stranded DNA binding
|
53 |
28 |
3 |
21 |
0 |
3 |
MF |
GO:0060089;molecular transducer activity |
GO:0003707;steroid hormone receptor activity
|
215 |
100 |
5 |
61 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0051425;PTB domain binding
|
30 |
13 |
0 |
11 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004715;non-membrane spanning protein tyrosine kinase activity
|
20 |
10 |
0 |
6 |
0 |
0 |
MF |
GO:0098772;molecular function regulator |
GO:0005088;Ras guanyl-nucleotide exchange factor activity
|
7 |
4 |
0 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004683;calmodulin-dependent protein kinase activity
|
15 |
8 |
0 |
4 |
0 |
0 |
MF |
Unclassified; |
GO:0004704;NF-kappaB-inducing kinase activity
|
4 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016903;oxidoreductase activity, acting on the aldehyde or oxo group of donors
|
86 |
41 |
5 |
15 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004033;aldo-keto reductase (NADP) activity
|
22 |
13 |
0 |
6 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0046934;phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
21 |
15 |
3 |
8 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0003990;acetylcholinesterase activity
|
124 |
64 |
2 |
35 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0035173;histone kinase activity
|
37 |
16 |
2 |
8 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0008389;coumarin 7-hydroxylase activity
|
59 |
32 |
1 |
20 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0016712;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
28 |
23 |
2 |
9 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0004969;histamine receptor activity
|
19 |
12 |
4 |
9 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0035257;nuclear hormone receptor binding
|
3 |
3 |
1 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0035005;1-phosphatidylinositol-4-phosphate 3-kinase activity
|
23 |
11 |
0 |
6 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0031994;insulin-like growth factor I binding
|
20 |
10 |
0 |
6 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0016907;G-protein coupled acetylcholine receptor activity
|
29 |
24 |
5 |
8 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004435;phosphatidylinositol phospholipase C activity
|
27 |
22 |
5 |
7 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0043140;ATP-dependent 3'-5' DNA helicase activity
|
80 |
33 |
1 |
26 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0003684;damaged DNA binding
|
21 |
11 |
0 |
8 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0036094;small molecule binding
|
29 |
11 |
1 |
6 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0019903;protein phosphatase binding
|
18 |
10 |
1 |
8 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0005102;receptor binding
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
Unclassified; |
GO:0004707;MAP kinase activity
|
6 |
4 |
0 |
3 |
0 |
0 |
MF |
Unclassified; |
GO:0004708;MAP kinase kinase activity
|
8 |
5 |
0 |
4 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001784;phosphotyrosine residue binding
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0008134;transcription factor binding
|
68 |
27 |
1 |
17 |
0 |
1 |
MF |
GO:0060089;molecular transducer activity |
GO:0004887;thyroid hormone receptor activity
|
174 |
39 |
1 |
40 |
0 |
4 |
MF |
GO:0005215;transporter activity |
GO:0005234;extracellularly glutamate-gated ion channel activity
|
36 |
23 |
3 |
15 |
0 |
1 |
MF |
GO:0005215;transporter activity |
GO:0015277;kainate selective glutamate receptor activity
|
36 |
23 |
3 |
15 |
0 |
1 |
MF |
GO:0005215;transporter activity |
GO:0004971;AMPA glutamate receptor activity
|
36 |
22 |
3 |
14 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0005497;androgen binding
|
38 |
16 |
2 |
12 |
0 |
1 |
MF |
GO:0005215;transporter activity |
GO:0005330;dopamine:sodium symporter activity
|
38 |
17 |
4 |
8 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016614;oxidoreductase activity, acting on CH-OH group of donors
|
23 |
10 |
0 |
5 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0043546;molybdopterin cofactor binding
|
11 |
5 |
0 |
3 |
0 |
0 |
MF |
Unclassified; |
GO:0003906;DNA-(apurinic or apyrimidinic site) lyase activity
|
17 |
7 |
0 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016491;oxidoreductase activity
|
32 |
24 |
0 |
19 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0035240;dopamine binding
|
40 |
21 |
0 |
14 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0003824;catalytic activity
|
45 |
22 |
0 |
10 |
0 |
1 |
MF |
GO:0005215;transporter activity |
GO:0008381;mechanosensitive ion channel activity
|
33 |
17 |
0 |
9 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042610;CD8 receptor binding
|
25 |
15 |
3 |
6 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042608;T cell receptor binding
|
19 |
10 |
1 |
3 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042609;CD4 receptor binding
|
20 |
11 |
1 |
4 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0008353;RNA polymerase II carboxy-terminal domain kinase activity
|
11 |
8 |
0 |
5 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051525;NFAT protein binding
|
5 |
4 |
1 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0000978;RNA polymerase II proximal promoter sequence-specific DNA binding
|
44 |
10 |
1 |
11 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0050473;arachidonate 15-lipoxygenase activity
|
96 |
48 |
4 |
29 |
0 |
3 |
MF |
GO:0140110;transcription regulator activity |
GO:0001077;transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding
|
14 |
5 |
1 |
3 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0005178;integrin binding
|
20 |
5 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0032450;maltose alpha-glucosidase activity
|
43 |
19 |
3 |
12 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004558;alpha-1,4-glucosidase activity
|
25 |
12 |
3 |
8 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001221;transcription cofactor binding
|
9 |
4 |
2 |
3 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0008392;arachidonic acid epoxygenase activity
|
129 |
60 |
4 |
36 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004698;calcium-dependent protein kinase C activity
|
13 |
9 |
0 |
8 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0035403;histone kinase activity (H3-T6 specific)
|
16 |
12 |
0 |
11 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004699;calcium-independent protein kinase C activity
|
18 |
10 |
0 |
8 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004629;phospholipase C activity
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
Unclassified; |
GO:0004871;signal transducer activity
|
63 |
33 |
2 |
23 |
0 |
1 |
MF |
GO:0060089;molecular transducer activity |
GO:0008502;melatonin receptor activity
|
6 |
6 |
2 |
1 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0035259;glucocorticoid receptor binding
|
5 |
3 |
1 |
2 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0004996;thyroid-stimulating hormone receptor activity
|
105 |
40 |
3 |
35 |
0 |
2 |
MF |
GO:0060089;molecular transducer activity |
GO:0038181;bile acid receptor activity
|
532 |
204 |
7 |
133 |
0 |
12 |
MF |
GO:0003824;catalytic activity |
GO:0001758;retinal dehydrogenase activity
|
95 |
39 |
1 |
27 |
0 |
2 |
MF |
GO:0005215;transporter activity |
GO:0005248;voltage-gated sodium channel activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0005244;voltage-gated ion channel activity
|
3 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0047374;methylumbelliferyl-acetate deacetylase activity
|
36 |
19 |
0 |
6 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0099583;neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration
|
2 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015347;sodium-independent organic anion transmembrane transporter activity
|
151 |
51 |
3 |
41 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0036310;annealing helicase activity
|
23 |
5 |
0 |
5 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0031625;ubiquitin protein ligase binding
|
13 |
3 |
0 |
4 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0001588;dopamine neurotransmitter receptor activity, coupled via Gs
|
18 |
9 |
0 |
7 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0019900;kinase binding
|
9 |
3 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042826;histone deacetylase binding
|
12 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0098782;mechanosensitived potassium channel activity
|
17 |
9 |
0 |
6 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0003705;transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding
|
32 |
10 |
1 |
8 |
0 |
1 |
MF |
GO:0005215;transporter activity |
GO:0005329;dopamine transmembrane transporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015651;quaternary ammonium group transmembrane transporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015307;drug:proton antiporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0005333;norepinephrine transmembrane transporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0005277;acetylcholine transmembrane transporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0008513;secondary active organic cation transmembrane transporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051434;BH3 domain binding
|
24 |
15 |
0 |
6 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0019904;protein domain specific binding
|
8 |
3 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004497;monooxygenase activity
|
31 |
15 |
0 |
9 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004560;alpha-L-fucosidase activity
|
2 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0050543;icosatetraenoic acid binding
|
76 |
38 |
3 |
19 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0031694;alpha-2A adrenergic receptor binding
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004693;cyclin-dependent protein serine/threonine kinase activity
|
7 |
2 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001047;core promoter binding
|
6 |
2 |
1 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0050321;tau-protein kinase activity
|
2 |
2 |
0 |
2 |
0 |
0 |
MF |
Unclassified; |
GO:0004705;JUN kinase activity
|
9 |
1 |
0 |
3 |
0 |
0 |
MF |
Unclassified; |
GO:0008349;MAP kinase kinase kinase kinase activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0019901;protein kinase binding
|
38 |
9 |
2 |
6 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0016787;hydrolase activity
|
4 |
2 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004697;protein kinase C activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0003677;DNA binding
|
6 |
2 |
0 |
3 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0005030;neurotrophin receptor activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0000287;magnesium ion binding
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0005007;fibroblast growth factor-activated receptor activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004301;epoxide hydrolase activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0008289;lipid binding
|
8 |
3 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0051213;dioxygenase activity
|
22 |
10 |
2 |
6 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0032795;heterotrimeric G-protein binding
|
6 |
6 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0047555;3',5'-cyclic-GMP phosphodiesterase activity
|
2 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051721;protein phosphatase 2A binding
|
121 |
40 |
3 |
26 |
0 |
6 |
MF |
GO:0005488;binding |
GO:0042923;neuropeptide binding
|
2 |
2 |
1 |
0 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0016323;basolateral plasma membrane
|
681 |
309 |
29 |
202 |
0 |
12 |
CC |
GO:0044464;cell part |
GO:0048471;perinuclear region of cytoplasm
|
180 |
78 |
2 |
53 |
0 |
5 |
CC |
GO:0043226;organelle |
GO:0005654;nucleoplasm
|
223 |
113 |
5 |
68 |
0 |
2 |
CC |
GO:0016020;membrane |
GO:0045121;membrane raft
|
172 |
80 |
4 |
60 |
0 |
5 |
CC |
GO:0016020;membrane |
GO:0005789;endoplasmic reticulum membrane
|
393 |
164 |
13 |
102 |
0 |
2 |
CC |
GO:0043226;organelle |
GO:0043231;intracellular membrane-bounded organelle
|
125 |
57 |
2 |
35 |
0 |
1 |
CC |
GO:0044425;membrane part |
GO:0005887;integral component of plasma membrane
|
286 |
131 |
15 |
85 |
0 |
9 |
CC |
GO:0032991;macromolecular complex |
GO:0043235;receptor complex
|
91 |
42 |
5 |
32 |
0 |
4 |
CC |
GO:0044464;cell part |
GO:0042995;cell projection
|
65 |
35 |
2 |
20 |
0 |
2 |
CC |
GO:0032991;macromolecular complex |
GO:0032133;chromosome passenger complex
|
76 |
32 |
4 |
13 |
0 |
2 |
CC |
GO:0044464;cell part |
GO:0099056;integral component of presynaptic membrane
|
225 |
135 |
10 |
79 |
0 |
4 |
CC |
GO:0016020;membrane |
GO:0005901;caveola
|
95 |
45 |
4 |
31 |
0 |
2 |
CC |
GO:0043226;organelle |
GO:0005634;nucleus
|
28 |
14 |
1 |
12 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:0005876;spindle microtubule
|
262 |
99 |
2 |
57 |
0 |
5 |
CC |
GO:0044464;cell part |
GO:0030424;axon
|
49 |
29 |
2 |
14 |
0 |
3 |
CC |
GO:0016020;membrane |
GO:0005886;plasma membrane
|
209 |
91 |
11 |
52 |
0 |
5 |
CC |
GO:0016020;membrane |
GO:0016020;membrane
|
125 |
61 |
3 |
40 |
0 |
8 |
CC |
GO:0044464;cell part |
GO:0005739;mitochondrion
|
55 |
28 |
0 |
22 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:0051233;spindle midzone
|
12 |
5 |
0 |
2 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0030673;axolemma
|
177 |
78 |
5 |
52 |
0 |
7 |
CC |
GO:0044456;synapse part |
GO:0099055;integral component of postsynaptic membrane
|
69 |
40 |
0 |
22 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005829;cytosol
|
94 |
49 |
0 |
30 |
0 |
3 |
CC |
GO:0044464;cell part |
GO:0031234;extrinsic component of cytoplasmic side of plasma membrane
|
56 |
25 |
0 |
19 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0005737;cytoplasm
|
43 |
20 |
1 |
11 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0032838;plasma membrane bounded cell projection cytoplasm
|
255 |
110 |
10 |
69 |
0 |
6 |
CC |
GO:0044464;cell part |
GO:0043204;perikaryon
|
63 |
40 |
3 |
21 |
0 |
1 |
CC |
GO:0044456;synapse part |
GO:0043679;axon terminus
|
25 |
20 |
3 |
4 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0014069;postsynaptic density
|
7 |
2 |
0 |
2 |
0 |
0 |
CC |
GO:0044456;synapse part |
GO:0045211;postsynaptic membrane
|
54 |
37 |
5 |
15 |
0 |
2 |
CC |
GO:0044456;synapse part |
GO:0042734;presynaptic membrane
|
6 |
4 |
0 |
2 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0008328;ionotropic glutamate receptor complex
|
6 |
3 |
0 |
2 |
0 |
0 |
CC |
GO:0045202;synapse |
GO:0032279;asymmetric synapse
|
18 |
13 |
1 |
3 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0001518;voltage-gated sodium channel complex
|
2 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0033268;node of Ranvier
|
2 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044456;synapse part |
GO:0048786;presynaptic active zone
|
2 |
2 |
1 |
1 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0031090;organelle membrane
|
237 |
100 |
5 |
59 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:0097730;non-motile cilium
|
29 |
13 |
0 |
10 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0060170;ciliary membrane
|
17 |
7 |
0 |
6 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0032839;dendrite cytoplasm
|
12 |
7 |
1 |
4 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0032983;kainate selective glutamate receptor complex
|
17 |
9 |
0 |
6 |
0 |
0 |
CC |
GO:0044456;synapse part |
GO:0043195;terminal bouton
|
18 |
10 |
0 |
7 |
0 |
0 |
CC |
GO:0030054;cell junction |
GO:0030054;cell junction
|
3 |
3 |
1 |
1 |
0 |
0 |
CC |
GO:0044421;extracellular region part |
GO:0070062;extracellular exosome
|
61 |
20 |
1 |
18 |
0 |
3 |
CC |
Unclassified; |
GO:0043234;protein complex
|
28 |
11 |
0 |
7 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005813;centrosome
|
2 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005641;nuclear envelope lumen
|
72 |
30 |
0 |
20 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0009986;cell surface
|
23 |
12 |
1 |
8 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0033256;I-kappaB/NF-kappaB complex
|
43 |
19 |
2 |
13 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0043005;neuron projection
|
31 |
14 |
1 |
8 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005884;actin filament
|
1 |
1 |
1 |
0 |
0 |
0 |
CC |
Unclassified; |
GO:0005902;microvillus
|
9 |
5 |
1 |
1 |
0 |
0 |
CC |
GO:0044456;synapse part |
GO:0097060;synaptic membrane
|
23 |
5 |
0 |
4 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0042470;melanosome
|
72 |
28 |
1 |
24 |
0 |
5 |
CC |
GO:0044464;cell part |
GO:0005783;endoplasmic reticulum
|
51 |
11 |
2 |
6 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007187;G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
|
4 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0035335;peptidyl-tyrosine dephosphorylation
|
305 |
130 |
3 |
73 |
0 |
8 |
BP |
GO:0009987;cellular process |
GO:1902202;regulation of hepatocyte growth factor receptor signaling pathway
|
407 |
161 |
4 |
95 |
0 |
8 |
BP |
GO:0065007;biological regulation |
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process
|
149 |
57 |
6 |
43 |
0 |
5 |
BP |
GO:0032501;multicellular organismal process |
GO:0019233;sensory perception of pain
|
53 |
19 |
0 |
14 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0006940;regulation of smooth muscle contraction
|
65 |
21 |
2 |
14 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046890;regulation of lipid biosynthetic process
|
11 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009750;response to fructose
|
32 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1901216;positive regulation of neuron death
|
61 |
21 |
0 |
16 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0006281;DNA repair
|
3 |
2 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:0051534;negative regulation of NFAT protein import into nucleus
|
4 |
2 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006631;fatty acid metabolic process
|
32 |
16 |
0 |
8 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0060338;regulation of type I interferon-mediated signaling pathway
|
54 |
16 |
0 |
8 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0033277;abortive mitotic cell cycle
|
28 |
11 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:1902894;negative regulation of pri-miRNA transcription from RNA polymerase II promoter
|
54 |
29 |
2 |
18 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0001523;retinoid metabolic process
|
19 |
6 |
0 |
8 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0002237;response to molecule of bacterial origin
|
12 |
5 |
0 |
7 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0046626;regulation of insulin receptor signaling pathway
|
263 |
111 |
3 |
68 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:1903897;regulation of PERK-mediated unfolded protein response
|
180 |
77 |
1 |
47 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0009755;hormone-mediated signaling pathway
|
13 |
7 |
0 |
6 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0032431;activation of phospholipase A2 activity
|
9 |
5 |
0 |
5 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest
|
7 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0031145;anaphase-promoting complex-dependent catabolic process
|
5 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0034501;protein localization to kinetochore
|
5 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0051583;dopamine uptake involved in synaptic transmission
|
32 |
11 |
2 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006066;alcohol metabolic process
|
12 |
5 |
2 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042133;neurotransmitter metabolic process
|
39 |
10 |
0 |
10 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042359;vitamin D metabolic process
|
9 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046483;heterocycle metabolic process
|
12 |
7 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0007584;response to nutrient
|
15 |
7 |
0 |
3 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015860;purine nucleoside transmembrane transport
|
39 |
27 |
0 |
14 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1904823;purine nucleobase transmembrane transport
|
74 |
42 |
5 |
22 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015855;pyrimidine nucleobase transport
|
74 |
42 |
5 |
22 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0009165;nucleotide biosynthetic process
|
7 |
6 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060736;prostate gland growth
|
32 |
9 |
0 |
6 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0030217;T cell differentiation
|
6 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0055088;lipid homeostasis
|
7 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0032024;positive regulation of insulin secretion
|
7 |
4 |
1 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0050872;white fat cell differentiation
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010745;negative regulation of macrophage derived foam cell differentiation
|
8 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046321;positive regulation of fatty acid oxidation
|
7 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0032966;negative regulation of collagen biosynthetic process
|
7 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0050968;detection of chemical stimulus involved in sensory perception of pain
|
21 |
10 |
1 |
6 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0050955;thermoception
|
22 |
11 |
1 |
7 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0047484;regulation of response to osmotic stress
|
25 |
11 |
0 |
6 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage
|
6 |
4 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006089;lactate metabolic process
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006284;base-excision repair
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0033004;negative regulation of mast cell activation
|
40 |
9 |
0 |
8 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0045759;negative regulation of action potential
|
40 |
9 |
0 |
8 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0050796;regulation of insulin secretion
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0001816;cytokine production
|
12 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0060032;notochord regression
|
32 |
8 |
1 |
9 |
0 |
1 |
BP |
GO:0032502;developmental process |
GO:0007418;ventral midline development
|
32 |
8 |
1 |
9 |
0 |
1 |
BP |
GO:0032502;developmental process |
GO:0021696;cerebellar cortex morphogenesis
|
31 |
7 |
1 |
8 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0007507;heart development
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0072531;pyrimidine-containing compound transmembrane transport
|
2 |
2 |
1 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0050729;positive regulation of inflammatory response
|
4 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:0048660;regulation of smooth muscle cell proliferation
|
25 |
10 |
0 |
7 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0060548;negative regulation of cell death
|
35 |
9 |
1 |
10 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0002532;production of molecular mediator involved in inflammatory response
|
5 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0042632;cholesterol homeostasis
|
64 |
17 |
2 |
15 |
0 |
4 |
BP |
GO:0032501;multicellular organismal process |
GO:0014005;microglia development
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0032640;tumor necrosis factor production
|
6 |
4 |
0 |
1 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0042446;hormone biosynthetic process
|
19 |
11 |
0 |
6 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016311;dephosphorylation
|
50 |
19 |
0 |
11 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:1904357;negative regulation of telomere maintenance via telomere lengthening
|
21 |
13 |
2 |
9 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1904646;cellular response to amyloid-beta
|
7 |
5 |
0 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0070212;protein poly-ADP-ribosylation
|
17 |
11 |
2 |
7 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001054;negative regulation of mesenchymal cell apoptotic process
|
14 |
5 |
1 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:1900113;negative regulation of histone H3-K9 trimethylation
|
6 |
1 |
0 |
0 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0006820;anion transport
|
5 |
1 |
0 |
0 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0015812;gamma-aminobutyric acid transport
|
5 |
2 |
0 |
1 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0070544;histone H3-K36 demethylation
|
4 |
1 |
0 |
0 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0033169;histone H3-K9 demethylation
|
4 |
1 |
0 |
0 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0009966;regulation of signal transduction
|
3 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0050790;regulation of catalytic activity
|
6 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1904064;positive regulation of cation transmembrane transport
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0002028;regulation of sodium ion transport
|
17 |
5 |
0 |
5 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0031223;auditory behavior
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0009299;mRNA transcription
|
9 |
5 |
1 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046320;regulation of fatty acid oxidation
|
4 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0001922;B-1 B cell homeostasis
|
2 |
2 |
0 |
2 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:1900274;regulation of phospholipase C activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0008088;axo-dendritic transport
|
3 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1990000;amyloid fibril formation
|
36 |
9 |
0 |
12 |
0 |
3 |
BP |
GO:0051179;localization |
GO:0006869;lipid transport
|
4 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007189;adenylate cyclase-activating G-protein coupled receptor signaling pathway
|
10 |
6 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0005975;carbohydrate metabolic process
|
12 |
5 |
0 |
1 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0007586;digestion
|
8 |
4 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0060336;negative regulation of interferon-gamma-mediated signaling pathway
|
8 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007186;G-protein coupled receptor signaling pathway
|
11 |
4 |
1 |
4 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0032368;regulation of lipid transport
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0050890;cognition
|
2 |
2 |
1 |
1 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:0048662;negative regulation of smooth muscle cell proliferation
|
4 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0001959;regulation of cytokine-mediated signaling pathway
|
33 |
8 |
0 |
7 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0007611;learning or memory
|
10 |
5 |
0 |
1 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0050951;sensory perception of temperature stimulus
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0006810;transport
|
9 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0048699;generation of neurons
|
33 |
9 |
0 |
10 |
0 |
3 |
BP |
GO:0065007;biological regulation |
GO:0031648;protein destabilization
|
6 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0008152;metabolic process
|
4 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0045834;positive regulation of lipid metabolic process
|
7 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015909;long-chain fatty acid transport
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0050806;positive regulation of synaptic transmission
|
4 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016926;protein desumoylation
|
2 |
2 |
1 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001234;negative regulation of apoptotic signaling pathway
|
8 |
4 |
0 |
2 |
0 |
2 |
BP |
GO:0051179;localization |
GO:1903829;positive regulation of cellular protein localization
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0090399;replicative senescence
|
4 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0035556;intracellular signal transduction
|
4 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0060359;response to ammonium ion
|
3 |
3 |
1 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0033602;negative regulation of dopamine secretion
|
3 |
3 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:1903715;regulation of aerobic respiration
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0032502;developmental process
|
5 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0007612;learning
|
2 |
2 |
0 |
1 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0043252;sodium-independent organic anion transport
|
82 |
28 |
2 |
25 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0032481;positive regulation of type I interferon production
|
8 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902749;regulation of cell cycle G2/M phase transition
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0050804;modulation of chemical synaptic transmission
|
3 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0042908;xenobiotic transport
|
21 |
8 |
0 |
6 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009267;cellular response to starvation
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1901522;positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus
|
11 |
3 |
0 |
1 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0090322;regulation of superoxide metabolic process
|
4 |
2 |
0 |
0 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0051179;localization
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0018076;N-terminal peptidyl-lysine acetylation
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046069;cGMP catabolic process
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0060282;positive regulation of oocyte development
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071321;cellular response to cGMP
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051091;positive regulation of DNA binding transcription factor activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0031670;cellular response to nutrient
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006000;fructose metabolic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071453;cellular response to oxygen levels
|
5 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0001774;microglial cell activation
|
46 |
13 |
0 |
12 |
0 |
3 |
BP |
GO:0008152;metabolic process |
GO:0042445;hormone metabolic process
|
4 |
2 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0032613;interleukin-10 production
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0045637;regulation of myeloid cell differentiation
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0038093;Fc receptor signaling pathway
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042327;positive regulation of phosphorylation
|
2 |
2 |
0 |
1 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0051881;regulation of mitochondrial membrane potential
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0045745;positive regulation of G-protein coupled receptor protein signaling pathway
|
16 |
4 |
0 |
5 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004726;non-membrane spanning protein tyrosine phosphatase activity
|
253 |
100 |
2 |
60 |
0 |
5 |
MF |
GO:0005488;binding |
GO:0034452;dynactin binding
|
142 |
54 |
0 |
47 |
0 |
6 |
MF |
GO:0005488;binding |
GO:0036041;long-chain fatty acid binding
|
110 |
51 |
1 |
32 |
0 |
2 |
MF |
GO:0003824;catalytic activity |
GO:0004556;alpha-amylase activity
|
26 |
13 |
0 |
5 |
0 |
1 |
MF |
Unclassified; |
GO:0103025;alpha-amylase activity (releasing maltohexaose)
|
26 |
13 |
0 |
5 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0032052;bile acid binding
|
144 |
62 |
2 |
35 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004035;alkaline phosphatase activity
|
10 |
4 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0043169;cation binding
|
9 |
8 |
0 |
4 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015125;bile acid transmembrane transporter activity
|
156 |
59 |
3 |
43 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0048037;cofactor binding
|
31 |
12 |
0 |
7 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0030332;cyclin binding
|
33 |
9 |
0 |
8 |
0 |
2 |
MF |
GO:0005215;transporter activity |
GO:0015291;secondary active transmembrane transporter activity
|
31 |
8 |
1 |
7 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042165;neurotransmitter binding
|
37 |
13 |
0 |
10 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0070324;thyroid hormone binding
|
31 |
15 |
1 |
6 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0042578;phosphoric ester hydrolase activity
|
6 |
4 |
1 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0030971;receptor tyrosine kinase binding
|
110 |
24 |
1 |
15 |
0 |
2 |
MF |
GO:0005215;transporter activity |
GO:0005328;neurotransmitter:sodium symporter activity
|
4 |
4 |
1 |
0 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015389;pyrimidine- and adenine-specific:sodium symporter activity
|
74 |
42 |
5 |
22 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015211;purine nucleoside transmembrane transporter activity
|
39 |
27 |
0 |
14 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0019206;nucleoside kinase activity
|
10 |
8 |
0 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004725;protein tyrosine phosphatase activity
|
85 |
26 |
1 |
15 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0002039;p53 binding
|
18 |
10 |
0 |
8 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0008013;beta-catenin binding
|
18 |
8 |
0 |
3 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0004955;prostaglandin receptor activity
|
36 |
18 |
1 |
10 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0046965;retinoid X receptor binding
|
125 |
30 |
1 |
35 |
0 |
4 |
MF |
GO:0005215;transporter activity |
GO:0097603;temperature-gated ion channel activity
|
14 |
8 |
1 |
6 |
0 |
1 |
MF |
GO:0005215;transporter activity |
GO:0015278;calcium-release channel activity
|
21 |
11 |
1 |
7 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0004459;L-lactate dehydrogenase activity
|
2 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0008559;xenobiotic transmembrane transporting ATPase activity
|
79 |
30 |
1 |
19 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0030165;PDZ domain binding
|
16 |
8 |
0 |
5 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016702;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
4 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0097200;cysteine-type endopeptidase activity involved in execution phase of apoptosis
|
56 |
22 |
0 |
19 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0019899;enzyme binding
|
29 |
12 |
0 |
8 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0046983;protein dimerization activity
|
23 |
12 |
0 |
5 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001085;RNA polymerase II transcription factor binding
|
41 |
14 |
0 |
7 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016791;phosphatase activity
|
42 |
8 |
1 |
6 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0003950;NAD+ ADP-ribosyltransferase activity
|
21 |
13 |
2 |
9 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0005332;gamma-aminobutyric acid:sodium symporter activity
|
10 |
5 |
1 |
2 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0051864;histone demethylase activity (H3-K36 specific)
|
6 |
1 |
0 |
0 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0032454;histone demethylase activity (H3-K9 specific)
|
6 |
2 |
0 |
0 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0016788;hydrolase activity, acting on ester bonds
|
17 |
7 |
1 |
2 |
0 |
1 |
MF |
GO:0060089;molecular transducer activity |
GO:0001875;lipopolysaccharide receptor activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0005319;lipid transporter activity
|
13 |
5 |
0 |
5 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0000980;RNA polymerase II distal enhancer sequence-specific DNA binding
|
11 |
4 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001046;core promoter sequence-specific DNA binding
|
26 |
11 |
0 |
7 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0016705;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
41 |
20 |
0 |
12 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0004935;adrenergic receptor activity
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0008234;cysteine-type peptidase activity
|
3 |
3 |
1 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0097159;organic cyclic compound binding
|
7 |
7 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0035325;Toll-like receptor binding
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0050662;coenzyme binding
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0097677;STAT family protein binding
|
43 |
9 |
1 |
7 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004468;lysine N-acetyltransferase activity, acting on acetyl phosphate as donor
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0070491;repressing transcription factor binding
|
8 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004115;3',5'-cyclic-AMP phosphodiesterase activity
|
3 |
2 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0030553;cGMP binding
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004119;cGMP-inhibited cyclic-nucleotide phosphodiesterase activity
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0030552;cAMP binding
|
3 |
2 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004118;cGMP-stimulated cyclic-nucleotide phosphodiesterase activity
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001540;amyloid-beta binding
|
28 |
12 |
0 |
10 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0015030;Cajal body
|
16 |
7 |
0 |
4 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0097504;Gemini of coiled bodies
|
277 |
144 |
5 |
83 |
0 |
1 |
CC |
GO:0032991;macromolecular complex |
GO:0032797;SMN complex
|
244 |
125 |
5 |
73 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0034719;SMN-Sm protein complex
|
112 |
56 |
3 |
25 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:0000780;condensed nuclear chromosome, centromeric region
|
41 |
9 |
1 |
3 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0031616;spindle pole centrosome
|
41 |
9 |
1 |
3 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0000307;cyclin-dependent protein kinase holoenzyme complex
|
6 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005764;lysosome
|
145 |
54 |
6 |
39 |
0 |
7 |
CC |
GO:0043226;organelle |
GO:0016604;nuclear body
|
26 |
14 |
1 |
8 |
0 |
2 |
CC |
GO:0032991;macromolecular complex |
GO:0097136;Bcl-2 family protein complex
|
33 |
15 |
1 |
9 |
0 |
3 |
CC |
Unclassified; |
GO:0097386;glial cell projection
|
5 |
5 |
0 |
3 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0032991;macromolecular complex
|
18 |
6 |
0 |
3 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0000784;nuclear chromosome, telomeric region
|
14 |
8 |
1 |
6 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005773;vacuole
|
6 |
2 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0000242;pericentriolar material
|
12 |
8 |
2 |
3 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005770;late endosome
|
38 |
14 |
0 |
10 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:0031982;vesicle
|
7 |
4 |
0 |
3 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0031233;intrinsic component of external side of plasma membrane
|
11 |
5 |
0 |
3 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0000800;lateral element
|
3 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0043229;intracellular organelle
|
4 |
2 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005635;nuclear envelope
|
141 |
48 |
5 |
45 |
0 |
5 |
CC |
GO:0044422;organelle part |
GO:0000781;chromosome, telomeric region
|
7 |
3 |
0 |
1 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0030018;Z disc
|
2 |
2 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0036021;endolysosome lumen
|
5 |
4 |
1 |
3 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0035578;azurophil granule lumen
|
25 |
9 |
1 |
4 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0016607;nuclear speck
|
60 |
25 |
2 |
19 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0043181;vacuolar sequestering
|
39 |
15 |
1 |
10 |
0 |
0 |
BP |
Unclassified; |
GO:0035105;sterol regulatory element binding protein import into nucleus
|
149 |
50 |
6 |
48 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0002086;diaphragm contraction
|
29 |
11 |
0 |
8 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0005985;sucrose metabolic process
|
30 |
12 |
0 |
8 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0036378;calcitriol biosynthetic process from calciol
|
33 |
15 |
0 |
7 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005638;lamin filament
|
321 |
132 |
10 |
100 |
0 |
6 |
CC |
GO:0044464;cell part |
GO:0035577;azurophil granule membrane
|
40 |
15 |
0 |
9 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0101003;ficolin-1-rich granule membrane
|
35 |
12 |
0 |
9 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0070821;tertiary granule membrane
|
41 |
15 |
0 |
10 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0043202;lysosomal lumen
|
46 |
19 |
0 |
10 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0050649;testosterone 6-beta-hydroxylase activity
|
79 |
36 |
0 |
20 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0033780;taurochenodeoxycholate 6alpha-hydroxylase activity
|
82 |
37 |
1 |
21 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0050591;quinine 3-monooxygenase activity
|
82 |
36 |
1 |
20 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0047638;albendazole monooxygenase activity
|
76 |
37 |
1 |
20 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0102320;1,8-cineole 2-exo-monooxygenase activity
|
92 |
43 |
1 |
23 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004574;oligo-1,6-glucosidase activity
|
53 |
21 |
2 |
14 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0030343;vitamin D3 25-hydroxylase activity
|
40 |
18 |
0 |
12 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0071615;oxidative deethylation
|
25 |
13 |
0 |
10 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0072734;cellular response to staurosporine
|
7 |
5 |
0 |
5 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0030678;mitochondrial ribonuclease P complex
|
62 |
26 |
2 |
17 |
0 |
1 |
CC |
GO:0032991;macromolecular complex |
GO:0097179;protease inhibitor complex
|
46 |
15 |
0 |
16 |
0 |
1 |
CC |
GO:0032991;macromolecular complex |
GO:0072558;NLRP1 inflammasome complex
|
46 |
15 |
0 |
16 |
0 |
1 |
CC |
GO:0032991;macromolecular complex |
GO:0072557;IPAF inflammasome complex
|
46 |
15 |
0 |
16 |
0 |
1 |
CC |
GO:0032991;macromolecular complex |
GO:0097169;AIM2 inflammasome complex
|
46 |
15 |
0 |
16 |
0 |
1 |
CC |
GO:0044422;organelle part |
GO:0005758;mitochondrial intermembrane space
|
23 |
11 |
0 |
10 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0008709;cholate 7-alpha-dehydrogenase activity
|
61 |
25 |
2 |
17 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0047015;3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity
|
61 |
25 |
2 |
17 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0030951;establishment or maintenance of microtubule cytoskeleton polarity
|
32 |
11 |
2 |
11 |
0 |
0 |
BP |
Unclassified; |
GO:2000189;positive regulation of cholesterol homeostasis
|
40 |
12 |
1 |
13 |
0 |
4 |
BP |
GO:0051704;multi-organism process |
GO:0052405;negative regulation by host of symbiont molecular function
|
47 |
14 |
1 |
15 |
0 |
4 |
BP |
GO:0008283;cell proliferation |
GO:0072201;negative regulation of mesenchymal cell proliferation
|
19 |
5 |
2 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007084;mitotic nuclear envelope reassembly
|
19 |
5 |
2 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071404;cellular response to low-density lipoprotein particle stimulus
|
38 |
12 |
1 |
13 |
0 |
4 |
BP |
Unclassified; |
GO:2000188;regulation of cholesterol homeostasis
|
42 |
14 |
1 |
15 |
0 |
4 |
BP |
GO:0032502;developmental process |
GO:0090343;positive regulation of cell aging
|
19 |
5 |
2 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0090201;negative regulation of release of cytochrome c from mitochondria
|
19 |
5 |
2 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0031579;membrane raft organization
|
38 |
12 |
1 |
13 |
0 |
4 |
BP |
GO:0032501;multicellular organismal process |
GO:0034383;low-density lipoprotein particle clearance
|
38 |
12 |
1 |
13 |
0 |
4 |
BP |
GO:0051179;localization |
GO:0033344;cholesterol efflux
|
48 |
15 |
1 |
14 |
0 |
4 |
BP |
GO:0008152;metabolic process |
GO:0016242;negative regulation of macroautophagy
|
38 |
12 |
1 |
13 |
0 |
4 |
BP |
GO:0008152;metabolic process |
GO:0008206;bile acid metabolic process
|
41 |
14 |
1 |
15 |
0 |
4 |
BP |
GO:0051179;localization |
GO:0034613;cellular protein localization
|
7 |
2 |
2 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0036498;IRE1-mediated unfolded protein response
|
21 |
5 |
2 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0045921;positive regulation of exocytosis
|
47 |
14 |
1 |
15 |
0 |
4 |
BP |
GO:0051179;localization |
GO:0042147;retrograde transport, endosome to Golgi
|
47 |
14 |
1 |
15 |
0 |
4 |
BP |
GO:0051179;localization |
GO:0007041;lysosomal transport
|
38 |
12 |
1 |
13 |
0 |
4 |
BP |
GO:0051179;localization |
GO:0006606;protein import into nucleus
|
22 |
7 |
3 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0008203;cholesterol metabolic process
|
38 |
12 |
1 |
13 |
0 |
4 |
BP |
GO:0051179;localization |
GO:0090150;establishment of protein localization to membrane
|
10 |
4 |
1 |
4 |
0 |
1 |
BP |
GO:0051179;localization |
GO:1900180;regulation of protein localization to nucleus
|
19 |
5 |
2 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006486;protein glycosylation
|
10 |
5 |
1 |
5 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:0030670;phagocytic vesicle membrane
|
67 |
24 |
1 |
25 |
0 |
4 |
CC |
GO:0044422;organelle part |
GO:0032588;trans-Golgi network membrane
|
82 |
28 |
2 |
23 |
0 |
4 |
CC |
GO:0044464;cell part |
GO:0031902;late endosome membrane
|
67 |
20 |
1 |
18 |
0 |
4 |
CC |
GO:0044464;cell part |
GO:0030133;transport vesicle
|
12 |
5 |
1 |
5 |
0 |
1 |
CC |
GO:0016020;membrane |
GO:0031965;nuclear membrane
|
32 |
12 |
2 |
9 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015248;sterol transporter activity
|
62 |
18 |
3 |
15 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0015485;cholesterol binding
|
41 |
14 |
2 |
13 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0019003;GDP binding
|
74 |
23 |
2 |
20 |
0 |
4 |
MF |
GO:0003824;catalytic activity |
GO:0003924;GTPase activity
|
31 |
8 |
1 |
6 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0097254;renal tubular secretion
|
36 |
8 |
0 |
11 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1904588;cellular response to glycoprotein
|
86 |
32 |
4 |
24 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:1905229;cellular response to thyrotropin-releasing hormone
|
57 |
19 |
1 |
20 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1903825;organic acid transmembrane transport
|
34 |
6 |
0 |
10 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0030814;regulation of cAMP metabolic process
|
37 |
7 |
0 |
10 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0031404;chloride ion binding
|
34 |
6 |
0 |
10 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015143;urate transmembrane transporter activity
|
34 |
6 |
0 |
10 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0005452;inorganic anion exchanger activity
|
35 |
7 |
0 |
10 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015301;anion:anion antiporter activity
|
35 |
7 |
0 |
10 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0072615;interleukin-17 secretion
|
189 |
46 |
1 |
49 |
0 |
5 |
BP |
GO:0019740;nitrogen utilization |
GO:2001250;positive regulation of ammonia assimilation cycle
|
139 |
34 |
1 |
35 |
0 |
4 |
BP |
GO:0019740;nitrogen utilization |
GO:0001080;nitrogen catabolite activation of transcription from RNA polymerase II promoter
|
135 |
34 |
1 |
35 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:0038184;cell surface bile acid receptor signaling pathway
|
17 |
9 |
0 |
10 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0005719;nuclear euchromatin
|
244 |
68 |
1 |
67 |
0 |
7 |
MF |
GO:0060089;molecular transducer activity |
GO:0038182;G-protein coupled bile acid receptor activity
|
77 |
34 |
0 |
28 |
0 |
2 |
MF |
GO:0005488;binding |
GO:1902122;chenodeoxycholic acid binding
|
240 |
69 |
1 |
65 |
0 |
8 |
MF |
GO:0005488;binding |
GO:0016922;ligand-dependent nuclear receptor binding
|
98 |
23 |
1 |
27 |
0 |
4 |
BP |
GO:0008152;metabolic process |
GO:1905695;positive regulation of phosphatidic acid biosynthetic process
|
56 |
6 |
1 |
11 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0038185;intracellular bile acid receptor signaling pathway
|
119 |
26 |
1 |
30 |
0 |
4 |
CC |
GO:0044464;cell part |
GO:0032590;dendrite membrane
|
22 |
4 |
0 |
3 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0038046;enkephalin receptor activity
|
34 |
8 |
0 |
6 |
0 |
2 |
CC |
Unclassified; |
GO:0031528;microvillus membrane
|
75 |
32 |
0 |
27 |
0 |
2 |
CC |
GO:0044464;cell part |
GO:0045177;apical part of cell
|
30 |
15 |
1 |
8 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060048;cardiac muscle contraction
|
10 |
3 |
1 |
2 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0032223;negative regulation of synaptic transmission, cholinergic
|
25 |
11 |
1 |
8 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0045212;neurotransmitter receptor biosynthetic process
|
26 |
11 |
1 |
9 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0045083;negative regulation of interleukin-12 biosynthetic process
|
10 |
5 |
1 |
3 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0071529;cementum mineralization
|
7 |
4 |
1 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006581;acetylcholine catabolic process
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0097745;mitochondrial tRNA 5'-end processing
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0003011;involuntary skeletal muscle contraction
|
2 |
2 |
1 |
0 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:1902937;inward rectifier potassium channel complex
|
2 |
2 |
1 |
1 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0031225;anchored component of membrane
|
39 |
13 |
1 |
11 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0065010;extracellular membrane-bounded organelle
|
10 |
7 |
1 |
3 |
0 |
0 |
CC |
GO:0005576;extracellular region |
GO:0043083;synaptic cleft
|
56 |
24 |
2 |
16 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0030283;testosterone dehydrogenase [NAD(P)] activity
|
50 |
17 |
2 |
11 |
0 |
1 |
MF |
GO:0060089;molecular transducer activity |
GO:0000155;phosphorelay sensor kinase activity
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0097070;ductus arteriosus closure
|
19 |
7 |
0 |
6 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0007567;parturition
|
13 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070493;thrombin-activated receptor signaling pathway
|
13 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0022414;reproductive process |
GO:0030728;ovulation
|
13 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006693;prostaglandin metabolic process
|
13 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0007565;female pregnancy
|
13 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0007179;transforming growth factor beta receptor signaling pathway
|
13 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0001822;kidney development
|
13 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0045786;negative regulation of cell cycle
|
4 |
4 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016404;15-hydroxyprostaglandin dehydrogenase (NAD+) activity
|
20 |
7 |
0 |
7 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0004957;prostaglandin E receptor activity
|
19 |
7 |
0 |
6 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0070403;NAD+ binding
|
13 |
6 |
0 |
5 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0008050;female courtship behavior
|
13 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0007621;negative regulation of female receptivity
|
9 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0061624;fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate
|
11 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060509;Type I pneumocyte differentiation
|
9 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0000012;single strand break repair
|
37 |
8 |
0 |
6 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0050884;neuromuscular process controlling posture
|
9 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006069;ethanol oxidation
|
11 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0046716;muscle cell cellular homeostasis
|
9 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0005980;glycogen catabolic process
|
14 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0002026;regulation of the force of heart contraction
|
9 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0003007;heart morphogenesis
|
9 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007040;lysosome organization
|
9 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0050885;neuromuscular process controlling balance
|
9 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0032508;DNA duplex unwinding
|
13 |
2 |
0 |
3 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0000724;double-strand break repair via homologous recombination
|
14 |
2 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006006;glucose metabolic process
|
9 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0007605;sensory perception of sound
|
9 |
2 |
0 |
2 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0030659;cytoplasmic vesicle membrane
|
19 |
8 |
0 |
7 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0017005;3'-tyrosyl-DNA phosphodiesterase activity
|
78 |
28 |
0 |
17 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0018479;benzaldehyde dehydrogenase (NAD+) activity
|
55 |
21 |
1 |
19 |
0 |
2 |
MF |
GO:0003824;catalytic activity |
GO:0004527;exonuclease activity
|
38 |
8 |
0 |
6 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0031490;chromatin DNA binding
|
18 |
4 |
0 |
3 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0003697;single-stranded DNA binding
|
51 |
15 |
0 |
12 |
0 |
1 |
CC |
GO:0044425;membrane part |
GO:0008076;voltage-gated potassium channel complex
|
3 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902215;negative regulation of interleukin-4-mediated signaling pathway
|
36 |
7 |
1 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070104;negative regulation of interleukin-6-mediated signaling pathway
|
36 |
7 |
1 |
4 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:1902233;negative regulation of positive thymic T cell selection
|
36 |
7 |
1 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902206;negative regulation of interleukin-2-mediated signaling pathway
|
35 |
6 |
1 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902227;negative regulation of macrophage colony-stimulating factor signaling pathway
|
33 |
4 |
1 |
2 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005793;endoplasmic reticulum-Golgi intermediate compartment
|
79 |
21 |
1 |
11 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0050839;cell adhesion molecule binding
|
35 |
5 |
1 |
2 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005811;lipid droplet
|
43 |
19 |
3 |
13 |
0 |
2 |
CC |
GO:0044464;cell part |
GO:0043209;myelin sheath
|
53 |
17 |
1 |
19 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0097260;eoxin A4 synthase activity
|
49 |
23 |
2 |
19 |
0 |
3 |
BP |
GO:0008152;metabolic process |
GO:0018401;peptidyl-proline hydroxylation to 4-hydroxy-L-proline
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0015886;heme transport
|
10 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0046598;positive regulation of viral entry into host cell
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0034378;chylomicron assembly
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0034379;very-low-density lipoprotein particle assembly
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046415;urate metabolic process
|
10 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902175;regulation of oxidative stress-induced intrinsic apoptotic signaling pathway
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0035722;interleukin-12-mediated signaling pathway
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0006879;cellular iron ion homeostasis
|
10 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0045454;cell redox homeostasis
|
17 |
7 |
0 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0006457;protein folding
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0034976;response to endoplasmic reticulum stress
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0043687;post-translational protein modification
|
4 |
2 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0016222;procollagen-proline 4-dioxygenase complex
|
14 |
7 |
1 |
4 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0034663;endoplasmic reticulum chaperone complex
|
15 |
7 |
1 |
4 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0009897;external side of plasma membrane
|
6 |
3 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0016324;apical plasma membrane
|
30 |
13 |
0 |
9 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005788;endoplasmic reticulum lumen
|
24 |
9 |
0 |
7 |
0 |
0 |
CC |
GO:0030054;cell junction |
GO:0005925;focal adhesion
|
6 |
3 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004656;procollagen-proline 4-dioxygenase activity
|
13 |
6 |
1 |
4 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015232;heme transporter activity
|
16 |
7 |
1 |
4 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0015037;peptide disulfide oxidoreductase activity
|
5 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0017127;cholesterol transporter activity
|
15 |
6 |
0 |
4 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0003756;protein disulfide isomerase activity
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0030850;prostate gland development
|
29 |
7 |
1 |
8 |
0 |
1 |
BP |
GO:0008283;cell proliferation |
GO:2000345;regulation of hepatocyte proliferation
|
29 |
7 |
1 |
8 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0009954;proximal/distal pattern formation
|
29 |
7 |
1 |
8 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0045880;positive regulation of smoothened signaling pathway
|
29 |
7 |
1 |
8 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0021983;pituitary gland development
|
29 |
7 |
1 |
8 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:1902808;positive regulation of cell cycle G1/S phase transition
|
29 |
7 |
1 |
8 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0009953;dorsal/ventral pattern formation
|
29 |
7 |
1 |
8 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0030324;lung development
|
33 |
8 |
1 |
10 |
0 |
1 |
BP |
GO:0032502;developmental process |
GO:0009913;epidermal cell differentiation
|
30 |
8 |
2 |
8 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0045667;regulation of osteoblast differentiation
|
29 |
7 |
1 |
8 |
0 |
1 |
BP |
GO:0023052;signaling |
GO:0090090;negative regulation of canonical Wnt signaling pathway
|
29 |
7 |
1 |
8 |
0 |
1 |
BP |
GO:0000003;reproduction |
GO:0007283;spermatogenesis
|
29 |
7 |
1 |
8 |
0 |
1 |
CC |
GO:0044422;organelle part |
GO:0097546;ciliary base
|
31 |
8 |
1 |
8 |
0 |
1 |
CC |
GO:0044422;organelle part |
GO:0097542;ciliary tip
|
31 |
8 |
1 |
9 |
0 |
1 |
CC |
GO:0044422;organelle part |
GO:0005930;axoneme
|
31 |
8 |
1 |
9 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0008017;microtubule binding
|
32 |
8 |
1 |
8 |
0 |
1 |
CC |
GO:0044425;membrane part |
GO:0031362;anchored component of external side of plasma membrane
|
8 |
3 |
0 |
2 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0031526;brush border membrane
|
8 |
3 |
0 |
3 |
0 |
1 |
CC |
GO:0032991;macromolecular complex |
GO:1990572;TERT-RMRP complex
|
18 |
11 |
1 |
8 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0000333;telomerase catalytic core complex
|
18 |
11 |
1 |
8 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0000783;nuclear telomere cap complex
|
10 |
5 |
0 |
4 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0035354;Toll-like receptor 1-Toll-like receptor 2 protein complex
|
54 |
16 |
1 |
16 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0016528;sarcoplasm
|
19 |
5 |
1 |
4 |
0 |
0 |
CC |
Unclassified; |
GO:0106003;amyloid-beta complex
|
53 |
15 |
1 |
15 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0030667;secretory granule membrane
|
20 |
5 |
1 |
4 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0008528;G-protein coupled peptide receptor activity
|
7 |
2 |
0 |
3 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2000819;regulation of nucleotide-excision repair
|
2 |
0 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010792;DNA double-strand break processing involved in repair via single-strand annealing
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0000730;DNA recombinase assembly
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006310;DNA recombination
|
2 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0032993;protein-DNA complex
|
13 |
7 |
0 |
6 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0086024;adrenergic receptor signaling pathway involved in positive regulation of heart rate
|
4 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:1901898;negative regulation of relaxation of cardiac muscle
|
5 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1990834;response to odorant
|
4 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0086023;adrenergic receptor signaling pathway involved in heart process
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0048102;autophagic cell death
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0022414;reproductive process |
GO:0060008;Sertoli cell differentiation
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042420;dopamine catabolic process
|
31 |
10 |
0 |
9 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:1901844;regulation of cell communication by electrical coupling involved in cardiac conduction
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0032754;positive regulation of interleukin-5 production
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071872;cellular response to epinephrine stimulus
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:0010839;negative regulation of keratinocyte proliferation
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016540;protein autoprocessing
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0010259;multicellular organism aging
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0022414;reproductive process |
GO:0046697;decidualization
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0033137;negative regulation of peptidyl-serine phosphorylation
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0060314;regulation of ryanodine-sensitive calcium-release channel activity
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0045822;negative regulation of heart contraction
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0031069;hair follicle morphogenesis
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0061028;establishment of endothelial barrier
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0032743;positive regulation of interleukin-2 production
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0034698;response to gonadotropin
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:0010880;regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0021675;nerve development
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0086004;regulation of cardiac muscle cell contraction
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2000249;regulation of actin cytoskeleton reorganization
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0045616;regulation of keratinocyte differentiation
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006576;cellular biogenic amine metabolic process
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0030593;neutrophil chemotaxis
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0032729;positive regulation of interferon-gamma production
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0035264;multicellular organism growth
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009749;response to glucose
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0050852;T cell receptor signaling pathway
|
3 |
2 |
0 |
0 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0005891;voltage-gated calcium channel complex
|
9 |
6 |
0 |
3 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0005741;mitochondrial outer membrane
|
50 |
18 |
1 |
12 |
0 |
2 |
CC |
GO:0044464;cell part |
GO:0030141;secretory granule
|
4 |
3 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0030984;kininogen binding
|
4 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016807;cysteine-type carboxypeptidase activity
|
4 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0031698;beta-2 adrenergic receptor binding
|
5 |
3 |
0 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0008131;primary amine oxidase activity
|
53 |
17 |
1 |
13 |
0 |
2 |
MF |
GO:0003824;catalytic activity |
GO:0004177;aminopeptidase activity
|
4 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0097110;scaffold protein binding
|
2 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051117;ATPase binding
|
4 |
3 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004197;cysteine-type endopeptidase activity
|
30 |
10 |
0 |
9 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0044325;ion channel binding
|
15 |
8 |
0 |
6 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042393;histone binding
|
5 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004252;serine-type endopeptidase activity
|
11 |
8 |
1 |
5 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042277;peptide binding
|
3 |
1 |
0 |
0 |
0 |
0 |
CC |
Unclassified; |
GO:0097454;Schwann cell microvillus
|
81 |
32 |
1 |
23 |
0 |
0 |
CC |
GO:0030054;cell junction |
GO:0033010;paranodal junction
|
77 |
30 |
1 |
21 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0043220;Schmidt-Lanterman incisure
|
76 |
28 |
1 |
20 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0043795;glyceraldehyde oxidoreductase activity
|
71 |
26 |
1 |
17 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010823;negative regulation of mitochondrion organization
|
39 |
19 |
1 |
10 |
0 |
1 |
BP |
GO:0071840;cellular component organization or biogenesis |
GO:1902988;neurofibrillary tangle assembly
|
87 |
26 |
0 |
26 |
0 |
5 |
CC |
GO:0044464;cell part |
GO:0097418;neurofibrillary tangle
|
188 |
68 |
3 |
50 |
0 |
7 |
CC |
GO:0032991;macromolecular complex |
GO:0045298;tubulin complex
|
189 |
68 |
3 |
50 |
0 |
7 |
CC |
GO:0044464;cell part |
GO:0036477;somatodendritic compartment
|
171 |
62 |
2 |
46 |
0 |
6 |
CC |
GO:0043226;organelle |
GO:0034399;nuclear periphery
|
114 |
36 |
1 |
33 |
0 |
4 |
MF |
GO:0005488;binding |
GO:0099609;microtubule lateral binding
|
117 |
39 |
2 |
34 |
0 |
6 |
MF |
GO:0005488;binding |
GO:0034185;apolipoprotein binding
|
65 |
18 |
0 |
19 |
0 |
4 |
BP |
GO:0009987;cellular process |
GO:1900103;positive regulation of endoplasmic reticulum unfolded protein response
|
39 |
13 |
0 |
7 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0010804;negative regulation of tumor necrosis factor-mediated signaling pathway
|
28 |
9 |
0 |
5 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0098554;cytoplasmic side of endoplasmic reticulum membrane
|
109 |
37 |
1 |
22 |
0 |
3 |
CC |
GO:0044464;cell part |
GO:0097443;sorting endosome
|
108 |
37 |
1 |
22 |
0 |
3 |
CC |
GO:0044456;synapse part |
GO:0032591;dendritic spine membrane
|
6 |
1 |
0 |
2 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0035855;megakaryocyte development
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0030220;platelet formation
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0022610;biological adhesion |
GO:0033628;regulation of cell adhesion mediated by integrin
|
2 |
2 |
0 |
1 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0042105;alpha-beta T cell receptor complex
|
2 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0032093;SAM domain binding
|
10 |
3 |
0 |
3 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0017124;SH3 domain binding
|
35 |
9 |
0 |
12 |
0 |
3 |
MF |
GO:0140110;transcription regulator activity |
GO:0001190;transcriptional activator activity, RNA polymerase II transcription factor binding
|
37 |
2 |
0 |
8 |
0 |
2 |
BP |
GO:0022610;biological adhesion |
GO:0090136;epithelial cell-cell adhesion
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:0070662;mast cell proliferation
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:1904343;positive regulation of colon smooth muscle contraction
|
1 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0099061;integral component of postsynaptic density membrane
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0005020;stem cell factor receptor activity
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016711;flavonoid 3'-monooxygenase activity
|
2 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0047696;beta-adrenergic receptor kinase activity
|
1 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0031931;TORC1 complex
|
10 |
5 |
0 |
2 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0001939;female pronucleus
|
1 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0031932;TORC2 complex
|
10 |
5 |
0 |
2 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0005942;phosphatidylinositol 3-kinase complex
|
3 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0031696;alpha-2C adrenergic receptor binding
|
5 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0002812;biosynthetic process of antibacterial peptides active against Gram-negative bacteria
|
2 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:1905689;positive regulation of diacylglycerol kinase activity
|
83 |
28 |
2 |
27 |
0 |
4 |
BP |
GO:0051704;multi-organism process |
GO:0070947;neutrophil mediated killing of fungus
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006518;peptide metabolic process
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0033619;membrane protein proteolysis
|
2 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0070931;Golgi-associated vesicle lumen
|
29 |
13 |
0 |
12 |
0 |
2 |
CC |
GO:0043226;organelle |
GO:0031410;cytoplasmic vesicle
|
2 |
1 |
0 |
2 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:1904115;axon cytoplasm
|
68 |
23 |
1 |
23 |
0 |
3 |
MF |
GO:0003824;catalytic activity |
GO:0070524;11-beta-hydroxysteroid dehydrogenase (NADP+) activity
|
10 |
2 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0008242;omega peptidase activity
|
1 |
0 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004190;aspartic-type endopeptidase activity
|
8 |
3 |
0 |
4 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0001104;RNA polymerase II transcription cofactor activity
|
1 |
0 |
0 |
1 |
0 |
0 |
CC |
GO:0044421;extracellular region part |
GO:0005605;basal lamina
|
51 |
20 |
1 |
14 |
0 |
0 |
CC |
GO:0045202;synapse |
GO:0031594;neuromuscular junction
|
28 |
12 |
0 |
8 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:1990730;VCP-NSFL1C complex
|
12 |
4 |
0 |
4 |
0 |
2 |
CC |
GO:0016020;membrane |
GO:0034098;VCP-NPL4-UFD1 AAA ATPase complex
|
10 |
2 |
0 |
2 |
0 |
1 |
CC |
GO:0016020;membrane |
GO:0036513;Derlin-1 retrotranslocation complex
|
7 |
1 |
0 |
1 |
0 |
1 |
MF |
GO:0060089;molecular transducer activity |
GO:0001587;Gq/11-coupled serotonin receptor activity
|
11 |
3 |
0 |
3 |
0 |
2 |
MF |
GO:0098772;molecular function regulator |
GO:0035800;deubiquitinase activator activity
|
12 |
4 |
0 |
4 |
0 |
2 |
MF |
GO:0003824;catalytic activity |
GO:0008798;beta-aspartyl-peptidase activity
|
26 |
11 |
0 |
10 |
0 |
2 |
BP |
GO:0032502;developmental process |
GO:0090258;negative regulation of mitochondrial fission
|
48 |
12 |
0 |
14 |
0 |
3 |
BP |
GO:0051179;localization |
GO:1903748;negative regulation of establishment of protein localization to mitochondrion
|
33 |
8 |
0 |
10 |
0 |
3 |
BP |
GO:0051179;localization |
GO:1902474;positive regulation of protein localization to synapse
|
33 |
8 |
0 |
10 |
0 |
3 |
BP |
GO:0051179;localization |
GO:0048312;intracellular distribution of mitochondria
|
40 |
11 |
0 |
11 |
0 |
3 |
BP |
GO:0051179;localization |
GO:0072386;plus-end-directed organelle transport along microtubule
|
40 |
11 |
0 |
11 |
0 |
3 |
BP |
GO:0065007;biological regulation |
GO:0010917;negative regulation of mitochondrial membrane potential
|
32 |
8 |
0 |
10 |
0 |
3 |
BP |
Unclassified; |
GO:0045773;positive regulation of axon extension
|
32 |
8 |
0 |
10 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0031122;cytoplasmic microtubule organization
|
32 |
8 |
0 |
10 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:1900034;regulation of cellular response to heat
|
44 |
13 |
0 |
13 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:0050808;synapse organization
|
32 |
8 |
0 |
10 |
0 |
3 |
BP |
GO:0009987;cellular process |
GO:2001020;regulation of response to DNA damage stimulus
|
6 |
0 |
0 |
2 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0033673;negative regulation of kinase activity
|
4 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010506;regulation of autophagy
|
5 |
1 |
1 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0030426;growth cone
|
36 |
9 |
0 |
11 |
0 |
4 |
CC |
GO:0032991;macromolecular complex |
GO:0005875;microtubule associated complex
|
37 |
9 |
0 |
11 |
0 |
3 |
CC |
GO:0044464;cell part |
GO:0036464;cytoplasmic ribonucleoprotein granule
|
18 |
5 |
0 |
5 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:0005694;chromosome
|
8 |
3 |
1 |
3 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0043025;neuronal cell body
|
9 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0071813;lipoprotein particle binding
|
37 |
9 |
0 |
12 |
0 |
3 |
CC |
GO:0044464;cell part |
GO:0042629;mast cell granule
|
35 |
15 |
0 |
10 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0019898;extrinsic component of membrane
|
10 |
3 |
1 |
2 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0099568;cytoplasmic region
|
13 |
1 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0061418;regulation of transcription from RNA polymerase II promoter in response to hypoxia
|
33 |
8 |
0 |
11 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043620;regulation of DNA-templated transcription in response to stress
|
42 |
9 |
0 |
12 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0097238;cellular response to methylglyoxal
|
33 |
11 |
1 |
8 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004032;alditol:NADP+ 1-oxidoreductase activity
|
33 |
10 |
0 |
9 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006690;icosanoid metabolic process
|
13 |
6 |
0 |
5 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0030666;endocytic vesicle membrane
|
12 |
5 |
0 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0015966;diadenosine tetraphosphate biosynthetic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0072584;caveolin-mediated endocytosis
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
Unclassified; |
GO:0031143;pseudopodium
|
18 |
3 |
0 |
2 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0072686;mitotic spindle
|
3 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:1904813;ficolin-1-rich granule lumen
|
18 |
6 |
1 |
3 |
0 |
0 |
BP |
Unclassified; |
GO:0061833;protein localization to tricellular tight junction
|
8 |
0 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1902414;protein localization to cell junction
|
7 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0071840;cellular component organization or biogenesis |
GO:0071803;positive regulation of podosome assembly
|
7 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010744;positive regulation of macrophage derived foam cell differentiation
|
7 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009612;response to mechanical stimulus
|
7 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0090341;negative regulation of secretion of lysosomal enzymes
|
7 |
2 |
0 |
4 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0099040;ceramide translocation
|
13 |
5 |
0 |
5 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0044214;spanning component of plasma membrane
|
5 |
2 |
0 |
3 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0090575;RNA polymerase II transcription factor complex
|
24 |
11 |
0 |
11 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:0000790;nuclear chromatin
|
26 |
9 |
0 |
9 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0032810;sterol response element binding
|
8 |
2 |
0 |
4 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0099038;ceramide-translocating ATPase activity
|
15 |
7 |
0 |
7 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0090555;phosphatidylethanolamine-translocating ATPase activity
|
14 |
6 |
0 |
6 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0090554;phosphatidylcholine-translocating ATPase activity
|
12 |
5 |
0 |
5 |
0 |
0 |
BP |
Unclassified; |
GO:1905337;positive regulation of aggrephagy
|
19 |
7 |
0 |
6 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0016234;inclusion body
|
24 |
10 |
0 |
7 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0043033;isoamylase complex
|
7 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005814;centriole
|
15 |
8 |
0 |
5 |
0 |
0 |
MF |
Unclassified; |
GO:0102500;beta-maltose 4-alpha-glucanotransferase activity
|
4 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004134;4-alpha-glucanotransferase activity
|
4 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004135;amylo-alpha-1,6-glucosidase activity
|
4 |
0 |
0 |
0 |
0 |
0 |
MF |
Unclassified; |
GO:0102499;SHG alpha-glucan phosphorylase activity
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0008184;glycogen phosphorylase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0002060;purine nucleobase binding
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0007595;lactation
|
2 |
1 |
0 |
2 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0072559;NLRP3 inflammasome complex
|
38 |
9 |
0 |
11 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0016529;sarcoplasmic reticulum
|
20 |
9 |
0 |
5 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0019897;extrinsic component of plasma membrane
|
4 |
3 |
0 |
3 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004855;xanthine oxidase activity
|
16 |
9 |
0 |
5 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004854;xanthine dehydrogenase activity
|
7 |
5 |
0 |
5 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0042585;germinal vesicle
|
7 |
2 |
0 |
1 |
0 |
0 |
CC |
GO:0044421;extracellular region part |
GO:0031012;extracellular matrix
|
7 |
3 |
1 |
1 |
0 |
0 |
MF |
Unclassified; |
GO:0005198;structural molecule activity
|
5 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0010044;response to aluminum ion
|
28 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0045964;positive regulation of dopamine metabolic process
|
28 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0010269;response to selenium ion
|
27 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0007610;behavior |
GO:0045475;locomotor rhythm
|
27 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0051412;response to corticosterone
|
27 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0050896;response to stimulus |
GO:0043153;entrainment of circadian clock by photoperiod
|
28 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0051156;glucose 6-phosphate metabolic process
|
27 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0046835;carbohydrate phosphorylation
|
27 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0006096;glycolytic process
|
27 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0032502;developmental process |
GO:0021762;substantia nigra development
|
27 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0006090;pyruvate metabolic process
|
27 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0009987;cellular process |
GO:0001678;cellular glucose homeostasis
|
27 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0046496;nicotinamide nucleotide metabolic process
|
27 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0032502;developmental process |
GO:0007517;muscle organ development
|
32 |
11 |
0 |
9 |
0 |
2 |
BP |
GO:0008152;metabolic process |
GO:0019318;hexose metabolic process
|
28 |
9 |
1 |
8 |
0 |
2 |
BP |
GO:0065007;biological regulation |
GO:0050821;protein stabilization
|
28 |
8 |
0 |
8 |
0 |
2 |
CC |
GO:0044422;organelle part |
GO:0005740;mitochondrial envelope
|
32 |
10 |
0 |
11 |
0 |
2 |
CC |
GO:0044464;cell part |
GO:0005938;cell cortex
|
34 |
11 |
0 |
10 |
0 |
2 |
MF |
GO:0003824;catalytic activity |
GO:0019158;mannokinase activity
|
28 |
9 |
1 |
8 |
0 |
2 |
MF |
GO:0003824;catalytic activity |
GO:0008865;fructokinase activity
|
28 |
9 |
0 |
8 |
0 |
2 |
MF |
GO:0003824;catalytic activity |
GO:0004340;glucokinase activity
|
28 |
9 |
0 |
8 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0005536;glucose binding
|
28 |
9 |
0 |
9 |
0 |
2 |
MF |
GO:0005488;binding |
GO:0050660;flavin adenine dinucleotide binding
|
38 |
10 |
0 |
10 |
0 |
3 |
MF |
GO:0003824;catalytic activity |
GO:0004843;thiol-dependent ubiquitin-specific protease activity
|
27 |
8 |
0 |
8 |
0 |
2 |
BP |
GO:0032501;multicellular organismal process |
GO:0032682;negative regulation of chemokine production
|
17 |
4 |
0 |
5 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0035580;specific granule lumen
|
28 |
10 |
1 |
9 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0001076;transcription factor activity, RNA polymerase II transcription factor binding
|
17 |
4 |
0 |
5 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0003714;transcription corepressor activity
|
17 |
4 |
0 |
5 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0046671;negative regulation of retinal cell programmed cell death
|
5 |
2 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006061;sorbitol biosynthetic process
|
29 |
9 |
0 |
7 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0046930;pore complex
|
6 |
2 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042447;hormone catabolic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0050783;cocaine metabolic process
|
10 |
3 |
0 |
3 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0005802;trans-Golgi network
|
13 |
5 |
0 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042737;drug catabolic process
|
14 |
7 |
0 |
5 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0050663;cytokine secretion
|
3 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:2000213;positive regulation of glutamate metabolic process
|
3 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0034255;regulation of urea metabolic process
|
16 |
4 |
0 |
6 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0042497;triacyl lipopeptide binding
|
5 |
1 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006662;glycerol ether metabolic process
|
14 |
6 |
0 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:2000810;regulation of bicellular tight junction assembly
|
13 |
5 |
0 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0010803;regulation of tumor necrosis factor-mediated signaling pathway
|
40 |
10 |
0 |
10 |
0 |
2 |
CC |
GO:0032991;macromolecular complex |
GO:0008385;IkappaB kinase complex
|
13 |
5 |
0 |
5 |
0 |
1 |
CC |
GO:0044425;membrane part |
GO:0035631;CD40 receptor complex
|
14 |
6 |
0 |
5 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:0005759;mitochondrial matrix
|
19 |
7 |
0 |
6 |
0 |
1 |
CC |
GO:0044425;membrane part |
GO:0009898;cytoplasmic side of plasma membrane
|
12 |
4 |
0 |
4 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0015035;protein disulfide oxidoreductase activity
|
29 |
12 |
0 |
10 |
0 |
2 |
MF |
GO:0003824;catalytic activity |
GO:0008113;peptide-methionine (S)-S-oxide reductase activity
|
14 |
6 |
0 |
5 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0060397;JAK-STAT cascade involved in growth hormone signaling pathway
|
31 |
8 |
0 |
6 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0042326;negative regulation of phosphorylation
|
4 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051345;positive regulation of hydrolase activity
|
3 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation
|
4 |
2 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005777;peroxisome
|
12 |
6 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0031730;CCR5 chemokine receptor binding
|
5 |
4 |
1 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0070327;thyroid hormone transport
|
25 |
4 |
0 |
4 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0032580;Golgi cisterna membrane
|
13 |
6 |
0 |
4 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016971;flavin-linked sulfhydryl oxidase activity
|
16 |
6 |
0 |
5 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0046920;alpha-(1->3)-fucosyltransferase activity
|
13 |
6 |
0 |
4 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0042036;negative regulation of cytokine biosynthetic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:2000612;regulation of thyroid-stimulating hormone secretion
|
10 |
3 |
0 |
4 |
0 |
1 |
BP |
Unclassified; |
GO:2000594;positive regulation of metanephric DCT cell differentiation
|
8 |
3 |
0 |
3 |
0 |
1 |
BP |
GO:0032501;multicellular organismal process |
GO:0072305;negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis
|
7 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0039003;pronephric field specification
|
2 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0012506;vesicle membrane
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005776;autophagosome
|
16 |
8 |
0 |
5 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0005522;profilin binding
|
18 |
7 |
0 |
6 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0000979;RNA polymerase II core promoter sequence-specific DNA binding
|
5 |
1 |
0 |
2 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0061078;positive regulation of prostaglandin secretion involved in immune response
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0050178;phenylpyruvate tautomerase activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004167;dopachrome isomerase activity
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0071707;immunoglobulin heavy chain V-D-J recombination
|
12 |
4 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006694;steroid biosynthetic process
|
7 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:1990264;peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity
|
33 |
6 |
0 |
6 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0046370;fructose biosynthetic process
|
11 |
4 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1903827;regulation of cellular protein localization
|
3 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0044245;polysaccharide digestion
|
3 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005903;brush border
|
3 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0030246;carbohydrate binding
|
3 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004339;glucan 1,4-alpha-glucosidase activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004575;sucrose alpha-glucosidase activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0032934;sterol binding
|
9 |
6 |
0 |
4 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0000977;RNA polymerase II regulatory region sequence-specific DNA binding
|
12 |
5 |
0 |
4 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:1990180;mitochondrial tRNA 3'-end processing
|
5 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0003857;3-hydroxyacyl-CoA dehydrogenase activity
|
6 |
3 |
1 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0032652;regulation of interleukin-1 production
|
28 |
6 |
0 |
6 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0051287;NAD binding
|
33 |
9 |
0 |
8 |
0 |
1 |
BP |
GO:0050896;response to stimulus |
GO:0033552;response to vitamin B3
|
15 |
4 |
0 |
4 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0005657;replication fork
|
23 |
7 |
0 |
6 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0005669;transcription factor TFIID complex
|
19 |
5 |
0 |
4 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0016605;PML body
|
29 |
10 |
0 |
8 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0016363;nuclear matrix
|
25 |
8 |
0 |
6 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0001567;cholesterol 25-hydroxylase activity
|
17 |
5 |
0 |
5 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1901642;nucleoside transmembrane transport
|
1 |
1 |
1 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:1904724;tertiary granule lumen
|
2 |
2 |
1 |
1 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:2000866;positive regulation of estradiol secretion
|
18 |
4 |
0 |
5 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006710;androgen catabolic process
|
15 |
2 |
0 |
4 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0002677;negative regulation of chronic inflammatory response
|
14 |
1 |
0 |
3 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0030540;female genitalia development
|
14 |
1 |
0 |
3 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0008585;female gonad development
|
14 |
1 |
0 |
3 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0030879;mammary gland development
|
14 |
1 |
0 |
3 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0001507;acetylcholine catabolic process in synaptic cleft
|
15 |
6 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046226;coumarin catabolic process
|
6 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0040016;embryonic cleavage
|
11 |
6 |
0 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006265;DNA topological change
|
11 |
6 |
0 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042982;amyloid precursor protein metabolic process
|
4 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006171;cAMP biosynthetic process
|
4 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0001919;regulation of receptor recycling
|
4 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006656;phosphatidylcholine biosynthetic process
|
4 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006796;phosphate-containing compound metabolic process
|
4 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042136;neurotransmitter biosynthetic process
|
4 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0031623;receptor internalization
|
4 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0060041;retina development in camera-type eye
|
4 |
3 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016925;protein sumoylation
|
11 |
6 |
0 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007059;chromosome segregation
|
11 |
6 |
0 |
4 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006338;chromatin remodeling
|
11 |
6 |
0 |
4 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0009330;DNA topoisomerase complex (ATP-hydrolyzing)
|
12 |
7 |
0 |
5 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0031298;replication fork protection complex
|
12 |
7 |
0 |
5 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005881;cytoplasmic microtubule
|
14 |
8 |
0 |
3 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0000228;nuclear chromosome
|
11 |
6 |
0 |
4 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0000932;P-body
|
11 |
6 |
0 |
4 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0001650;fibrillar center
|
13 |
7 |
0 |
5 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0003917;DNA topoisomerase type I activity
|
11 |
6 |
0 |
4 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0097100;supercoiled DNA binding
|
11 |
6 |
0 |
4 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0001594;trace-amine receptor activity
|
4 |
3 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042166;acetylcholine binding
|
11 |
8 |
1 |
2 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0043236;laminin binding
|
8 |
4 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005794;Golgi apparatus
|
9 |
5 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0048487;beta-tubulin binding
|
10 |
7 |
0 |
5 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:1904197;positive regulation of granulosa cell proliferation
|
5 |
2 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0043218;compact myelin
|
7 |
3 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004586;ornithine decarboxylase activity
|
7 |
2 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001156;TFIIIC-class transcription factor binding
|
7 |
3 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902235;regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway
|
4 |
3 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005769;early endosome
|
36 |
11 |
1 |
7 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0032421;stereocilium bundle
|
32 |
16 |
4 |
8 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:1903561;extracellular vesicle
|
2 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0097604;temperature-gated cation channel activity
|
28 |
14 |
4 |
7 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0032589;neuron projection membrane
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0014016;neuroblast differentiation
|
7 |
2 |
0 |
2 |
0 |
0 |
CC |
GO:0005576;extracellular region |
GO:0005576;extracellular region
|
9 |
2 |
1 |
1 |
0 |
0 |
CC |
GO:0044421;extracellular region part |
GO:0072562;blood microparticle
|
8 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0033265;choline binding
|
8 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0007598;blood coagulation, extrinsic pathway
|
8 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0017187;peptidyl-glutamic acid carboxylation
|
7 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0050435;amyloid-beta metabolic process
|
7 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0007597;blood coagulation, intrinsic pathway
|
7 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006465;signal peptide processing
|
7 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006509;membrane protein ectodomain proteolysis
|
7 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0006888;ER to Golgi vesicle-mediated transport
|
7 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0007596;blood coagulation
|
7 |
3 |
0 |
3 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005771;multivesicular body
|
8 |
4 |
0 |
3 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005796;Golgi lumen
|
7 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0032269;negative regulation of cellular protein metabolic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006195;purine nucleotide catabolic process
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001664;G-protein coupled receptor binding
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0031256;leading edge membrane
|
5 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0003779;actin binding
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0043547;positive regulation of GTPase activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0098772;molecular function regulator |
GO:0005096;GTPase activator activity
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0050708;regulation of protein secretion
|
2 |
2 |
0 |
2 |
0 |
0 |
CC |
GO:0044421;extracellular region part |
GO:0005578;proteinaceous extracellular matrix
|
7 |
6 |
1 |
4 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0030017;sarcomere
|
4 |
3 |
0 |
2 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0070553;nicotinic acid receptor activity
|
9 |
5 |
1 |
2 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005642;annulate lamellae
|
9 |
3 |
0 |
3 |
0 |
0 |
CC |
GO:0044215;other organism |
GO:0043657;host cell
|
7 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0000776;kinetochore
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006117;acetaldehyde metabolic process
|
9 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0014040;positive regulation of Schwann cell differentiation
|
8 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071224;cellular response to peptidoglycan
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0045084;positive regulation of interleukin-12 biosynthetic process
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070431;nucleotide-binding oligomerization domain containing 2 signaling pathway
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0016032;viral process
|
8 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071223;cellular response to lipoteichoic acid
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0033234;negative regulation of protein sumoylation
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0050862;positive regulation of T cell receptor signaling pathway
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0035729;cellular response to hepatocyte growth factor stimulus
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1901223;negative regulation of NIK/NF-kappaB signaling
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071354;cellular response to interleukin-6
|
8 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0032495;response to muramyl dipeptide
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0010224;response to UV-B
|
8 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0032332;positive regulation of chondrocyte differentiation
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0035994;response to muscle stretch
|
8 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0031293;membrane protein intracellular domain proteolysis
|
8 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0000289;nuclear-transcribed mRNA poly(A) tail shortening
|
8 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0001942;hair follicle development
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1901224;positive regulation of NIK/NF-kappaB signaling
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0032570;response to progesterone
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010501;RNA secondary structure unwinding
|
8 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0006968;cellular defense response
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071347;cellular response to interleukin-1
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0043200;response to amino acid
|
8 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042177;negative regulation of protein catabolic process
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002223;stimulatory C-type lectin receptor signaling pathway
|
8 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0033209;tumor necrosis factor-mediated signaling pathway
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006413;translational initiation
|
8 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0051607;defense response to virus
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling
|
8 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0035525;NF-kappaB p50/p65 complex
|
10 |
3 |
0 |
2 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0016281;eukaryotic translation initiation factor 4F complex
|
10 |
2 |
0 |
2 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0005667;transcription factor complex
|
9 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0071532;ankyrin repeat binding
|
9 |
3 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042301;phosphate ion binding
|
8 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0000339;RNA cap binding
|
9 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0000983;transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding
|
7 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051059;NF-kappaB binding
|
7 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0001205;transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding
|
8 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042805;actinin binding
|
9 |
3 |
0 |
3 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0003743;translation initiation factor activity
|
8 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0003725;double-stranded RNA binding
|
8 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0033613;activating transcription factor binding
|
7 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004004;ATP-dependent RNA helicase activity
|
8 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0047485;protein N-terminus binding
|
9 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0001078;transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding
|
7 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0003729;mRNA binding
|
7 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0003676;nucleic acid binding
|
21 |
3 |
0 |
3 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0090350;negative regulation of cellular organofluorine metabolic process
|
11 |
3 |
0 |
2 |
0 |
0 |
MF |
Unclassified; |
GO:0008384;IkappaB kinase activity
|
2 |
2 |
0 |
1 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0042383;sarcolemma
|
10 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0050966;detection of mechanical stimulus involved in sensory perception of pain
|
6 |
2 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0048265;response to pain
|
6 |
2 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009409;response to cold
|
7 |
2 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0002544;chronic inflammatory response
|
10 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0002526;acute inflammatory response
|
10 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0032526;response to retinoic acid
|
11 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0051592;response to calcium ion
|
10 |
3 |
0 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0050220;prostaglandin-E synthase activity
|
12 |
3 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0043295;glutathione binding
|
10 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0045184;establishment of protein localization
|
2 |
1 |
1 |
1 |
0 |
1 |
CC |
GO:0032991;macromolecular complex |
GO:0034687;integrin alphaL-beta2 complex
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0030369;ICAM-3 receptor activity
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001103;RNA polymerase II repressing transcription factor binding
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:2000646;positive regulation of receptor catabolic process
|
27 |
5 |
0 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:1903898;negative regulation of PERK-mediated unfolded protein response
|
27 |
5 |
0 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0035791;platelet-derived growth factor receptor-beta signaling pathway
|
27 |
5 |
0 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0030948;negative regulation of vascular endothelial growth factor receptor signaling pathway
|
27 |
5 |
0 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0006987;activation of signaling protein activity involved in unfolded protein response
|
27 |
5 |
0 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:1903896;positive regulation of IRE1-mediated unfolded protein response
|
27 |
5 |
0 |
5 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:1902236;negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway
|
25 |
4 |
0 |
4 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0007257;activation of JUN kinase activity
|
25 |
4 |
0 |
4 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0061098;positive regulation of protein tyrosine kinase activity
|
26 |
4 |
0 |
4 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0031532;actin cytoskeleton reorganization
|
25 |
4 |
0 |
4 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0070373;negative regulation of ERK1 and ERK2 cascade
|
25 |
4 |
0 |
4 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0043407;negative regulation of MAP kinase activity
|
26 |
4 |
0 |
4 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0006302;double-strand break repair
|
29 |
7 |
1 |
4 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0030100;regulation of endocytosis
|
25 |
4 |
0 |
4 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0090305;nucleic acid phosphodiester bond hydrolysis
|
21 |
5 |
0 |
4 |
0 |
1 |
BP |
GO:0051179;localization |
GO:0033157;regulation of intracellular protein transport
|
18 |
3 |
0 |
4 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0046875;ephrin receptor binding
|
28 |
6 |
1 |
5 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0005158;insulin receptor binding
|
27 |
5 |
0 |
5 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0045296;cadherin binding
|
21 |
4 |
0 |
5 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0070852;cell body fiber
|
4 |
4 |
0 |
4 |
0 |
1 |
CC |
GO:0045202;synapse |
GO:0045202;synapse
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0043198;dendritic shaft
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043335;protein unfolding
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0061684;chaperone-mediated autophagy
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0071840;cellular component organization or biogenesis |
GO:1905323;telomerase holoenzyme complex assembly
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0045040;protein import into mitochondrial outer membrane
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0042026;protein refolding
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0051131;chaperone-mediated protein complex assembly
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0007004;telomere maintenance via telomerase
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0050999;regulation of nitric-oxide synthase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0006986;response to unfolded protein
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009408;response to heat
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0071840;cellular component organization or biogenesis |
GO:0097711;ciliary basal body-plasma membrane docking
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0022406;membrane docking
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0006898;receptor-mediated endocytosis
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0031396;regulation of protein ubiquitination
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:0043623;cellular protein complex assembly
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043254;regulation of protein complex assembly
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0043312;neutrophil degranulation
|
4 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0051640;organelle localization
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0071682;endocytic vesicle lumen
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0032587;ruffle membrane
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0034774;secretory granule lumen
|
10 |
6 |
0 |
5 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0030911;TPR domain binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0070182;DNA polymerase binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0023026;MHC class II protein complex binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0097718;disordered domain specific binding
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:1990782;protein tyrosine kinase binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051082;unfolded protein binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016887;ATPase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051020;GTPase binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0070539;linoleic acid binding
|
14 |
5 |
1 |
4 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0097550;transcriptional preinitiation complex
|
4 |
3 |
0 |
2 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0035327;transcriptionally active chromatin
|
3 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001093;TFIIB-class transcription factor binding
|
3 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006720;isoprenoid metabolic process
|
7 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0055013;cardiac muscle cell development
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1904193;negative regulation of cholangiocyte apoptotic process
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:1904056;positive regulation of cholangiocyte proliferation
|
1 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0030425;dendrite
|
11 |
7 |
0 |
6 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001032;RNA polymerase III type 3 promoter DNA binding
|
1 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0097489;multivesicular body, internal vesicle lumen
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0070435;Shc-EGFR complex
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0030122;AP-2 adaptor complex
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0005006;epidermal growth factor-activated receptor activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0048408;epidermal growth factor binding
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006704;glucocorticoid biosynthetic process
|
5 |
2 |
0 |
2 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0030496;midbody
|
5 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0035176;social behavior
|
4 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0031514;motile cilium
|
8 |
4 |
0 |
3 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0030139;endocytic vesicle
|
25 |
5 |
0 |
3 |
0 |
0 |
CC |
GO:0044456;synapse part |
GO:0098794;postsynapse
|
4 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0032244;positive regulation of nucleoside transport
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0002540;leukotriene production involved in inflammatory response
|
6 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0070256;negative regulation of mucus secretion
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0042323;negative regulation of circadian sleep/wake cycle, non-REM sleep
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0032900;negative regulation of neurotrophin production
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:1900453;negative regulation of long term synaptic depression
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004051;arachidonate 5-lipoxygenase activity
|
8 |
3 |
0 |
2 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0043194;axon initial segment
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0008081;phosphoric diester hydrolase activity
|
3 |
2 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005768;endosome
|
3 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0001607;neuromedin U receptor activity
|
4 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0032611;interleukin-1 beta production
|
6 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0033198;response to ATP
|
6 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071260;cellular response to mechanical stimulus
|
5 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1901698;response to nitrogen compound
|
5 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0050715;positive regulation of cytokine secretion
|
5 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0035505;positive regulation of myosin light chain kinase activity
|
5 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0099503;secretory vesicle
|
6 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004175;endopeptidase activity
|
5 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0050700;CARD domain binding
|
5 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0098772;molecular function regulator |
GO:0008656;cysteine-type endopeptidase activator activity involved in apoptotic process
|
5 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0005149;interleukin-1 receptor binding
|
5 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0004992;platelet activating factor receptor activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
Unclassified; |
GO:0140067;peptidyl-lysine butyrylation
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
Unclassified; |
GO:0140066;peptidyl-lysine crotonylation
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
Unclassified; |
GO:0061921;peptidyl-lysine propionylation
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0043969;histone H2B acetylation
|
1 |
0 |
0 |
1 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0000123;histone acetyltransferase complex
|
1 |
0 |
0 |
1 |
0 |
0 |
MF |
Unclassified; |
GO:0140065;peptide butyryltransferase activity
|
1 |
0 |
0 |
1 |
0 |
0 |
MF |
Unclassified; |
GO:0140069;histone butyryltransferase activity
|
2 |
0 |
0 |
1 |
0 |
0 |
MF |
Unclassified; |
GO:0140068;histone crotonyltransferase activity
|
2 |
0 |
0 |
1 |
0 |
0 |
MF |
Unclassified; |
GO:0061920;protein propionyltransferase activity
|
2 |
0 |
0 |
1 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0003713;transcription coactivator activity
|
1 |
0 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0097157;pre-mRNA intronic binding
|
1 |
0 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0001750;photoreceptor outer segment
|
4 |
3 |
0 |
0 |
0 |
0 |
CC |
GO:0044217;other organism part |
GO:0044218;other organism cell membrane
|
4 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0031232;extrinsic component of external side of plasma membrane
|
4 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0043020;NADPH oxidase complex
|
5 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0008311;double-stranded DNA 3'-5' exodeoxyribonuclease activity
|
7 |
2 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016890;site-specific endodeoxyribonuclease activity, specific for altered base
|
6 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:1904854;proteasome core complex binding
|
4 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0019826;oxygen sensor activity
|
5 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070194;synaptonemal complex disassembly
|
2 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0000942;condensed nuclear chromosome outer kinetochore
|
2 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0000795;synaptonemal complex
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0010997;anaphase-promoting complex binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015085;calcium ion transmembrane transporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015276;ligand-gated ion channel activity
|
3 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0051972;regulation of telomerase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007154;cell communication
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005622;intracellular
|
4 |
2 |
0 |
1 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0000990;transcription factor activity, core RNA polymerase binding
|
4 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0031435;mitogen-activated protein kinase kinase kinase binding
|
4 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0050801;ion homeostasis
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005791;rough endoplasmic reticulum
|
7 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0070561;vitamin D receptor signaling pathway
|
3 |
0 |
0 |
1 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0010980;positive regulation of vitamin D 24-hydroxylase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0045202;synapse |
GO:0060077;inhibitory synapse
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0034702;ion channel complex
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0008434;calcitriol receptor activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0038186;lithocholic acid receptor activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:1902121;lithocholic acid binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0030977;taurine binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:1902098;calcitriol binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0031406;carboxylic acid binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0070644;vitamin D response element binding
|
4 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:1904121;phosphatidylethanolamine transporter activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1901074;regulation of engulfment of apoptotic cell
|
7 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0035963;cellular response to interleukin-13
|
7 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0035358;regulation of peroxisome proliferator activated receptor signaling pathway
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0005546;phosphatidylinositol-4,5-bisphosphate binding
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:1905920;positive regulation of CoA-transferase activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1905144;response to acetylcholine
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006288;base-excision repair, DNA ligation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
Unclassified; |
GO:0140059;dendrite arborization
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006287;base-excision repair, gap-filling
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0005892;acetylcholine-gated channel complex
|
5 |
5 |
1 |
2 |
0 |
1 |
CC |
GO:0016020;membrane |
GO:0044853;plasma membrane raft
|
3 |
2 |
0 |
1 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0098857;membrane microdomain
|
3 |
3 |
0 |
3 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0015643;toxic substance binding
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0022824;transmitter-gated ion channel activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0051281;positive regulation of release of sequestered calcium ion into cytosol
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0005000;vasopressin receptor activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0045505;dynein intermediate chain binding
|
8 |
4 |
0 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006584;catecholamine metabolic process
|
10 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0035987;endodermal cell differentiation
|
3 |
2 |
1 |
1 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0031436;BRCA1-BARD1 complex
|
1 |
1 |
1 |
0 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0070531;BRCA1-A complex
|
1 |
1 |
1 |
0 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0008274;gamma-tubulin ring complex
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1903242;regulation of cardiac muscle hypertrophy in response to stress
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007017;microtubule-based process
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0051081;nuclear envelope disassembly
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051563;smooth endoplasmic reticulum calcium ion homeostasis
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0051124;synaptic growth at neuromuscular junction
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
Unclassified; |
GO:0048669;collateral sprouting in absence of injury
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071874;cellular response to norepinephrine stimulus
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
Unclassified; |
GO:0061890;positive regulation of astrocyte activation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0050803;regulation of synapse structure or activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1905598;negative regulation of low-density lipoprotein receptor activity
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:1990812;growth cone filopodium
|
2 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:1990761;growth cone lamellipodium
|
2 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0044304;main axon
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
Unclassified; |
GO:0097449;astrocyte projection
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0035253;ciliary rootlet
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044456;synapse part |
GO:0043197;dendritic spine
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0098772;molecular function regulator |
GO:0016504;peptidase activator activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0005539;glycosaminoglycan binding
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004518;nuclease activity
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0060750;epithelial cell proliferation involved in mammary gland duct elongation
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0051223;regulation of protein transport
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042924;neuromedin U binding
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044421;extracellular region part |
GO:0005615;extracellular space
|
2 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0001781;neutrophil apoptotic process
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0070165;positive regulation of adiponectin secretion
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0035265;organ growth
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0046668;regulation of retinal cell programmed cell death
|
1 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0035370;UBC13-UEV1A complex
|
5 |
4 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0031372;UBC13-MMS2 complex
|
5 |
4 |
0 |
0 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0031966;mitochondrial membrane
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0022610;biological adhesion |
GO:0010810;regulation of cell-substrate adhesion
|
3 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0000793;condensed chromosome
|
8 |
3 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0031493;nucleosomal histone binding
|
7 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010507;negative regulation of autophagy
|
2 |
2 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0052689;carboxylic ester hydrolase activity
|
2 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0046943;carboxylic acid transmembrane transporter activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0031587;positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity
|
6 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0042297;vocal learning
|
6 |
3 |
0 |
3 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:1903489;positive regulation of lactation
|
23 |
5 |
1 |
2 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:1900100;positive regulation of plasma cell differentiation
|
22 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060691;epithelial cell maturation involved in salivary gland development
|
22 |
4 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0031017;exocrine pancreas development
|
22 |
4 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001158;enhancer sequence-specific DNA binding
|
22 |
5 |
0 |
3 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006636;unsaturated fatty acid biosynthetic process
|
2 |
2 |
1 |
1 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0032940;secretion by cell
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0045994;positive regulation of translational initiation by iron
|
2 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0040011;locomotion |
GO:0030336;negative regulation of cell migration
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0055012;ventricular cardiac muscle cell differentiation
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0004886;9-cis retinoic acid receptor activity
|
3 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0050692;DBD domain binding
|
3 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0044323;retinoic acid-responsive element binding
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0050693;LBD domain binding
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015349;thyroid hormone transmembrane transporter activity
|
4 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0000302;response to reactive oxygen species
|
3 |
3 |
1 |
2 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0014031;mesenchymal cell development
|
3 |
3 |
1 |
2 |
0 |
0 |
MF |
Unclassified; |
GO:0098680;template-free RNA nucleotidyltransferase
|
8 |
6 |
1 |
4 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0003721;telomerase RNA reverse transcriptase activity
|
6 |
4 |
1 |
3 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:1905062;positive regulation of cardioblast proliferation
|
2 |
0 |
0 |
1 |
0 |
1 |
BP |
GO:0008152;metabolic process |
GO:0030212;hyaluronan metabolic process
|
2 |
0 |
0 |
1 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0043024;ribosomal small subunit binding
|
2 |
0 |
0 |
1 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0030145;manganese ion binding
|
3 |
0 |
0 |
1 |
0 |
1 |
MF |
GO:0098772;molecular function regulator |
GO:0008083;growth factor activity
|
10 |
2 |
0 |
2 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0035639;purine ribonucleoside triphosphate binding
|
2 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0032555;purine ribonucleotide binding
|
3 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0018931;naphthalene metabolic process
|
15 |
5 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0015631;tubulin binding
|
3 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:1990708;conditioned place preference
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1903937;response to acrylamide
|
1 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005882;intermediate filament
|
2 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0038048;dynorphin receptor activity
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0002541;activation of plasma proteins involved in acute inflammatory response
|
3 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0002543;activation of blood coagulation via clotting cascade
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042428;serotonin metabolic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0035640;exploration behavior
|
3 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:1905286;serine-type peptidase complex
|
3 |
2 |
0 |
1 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0090722;receptor-receptor interaction
|
2 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0004896;cytokine receptor activity
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0002020;protease binding
|
4 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0031098;stress-activated protein kinase signaling cascade
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0035976;transcription factor AP-1 complex
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0051463;negative regulation of cortisol secretion
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0044648;histone H3-K4 dimethylation
|
4 |
1 |
1 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:2000751;histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:1901674;regulation of histone H3-K27 acetylation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:0071440;regulation of histone H3-K14 acetylation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:2001040;positive regulation of cellular response to drug
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0018026;peptidyl-lysine monomethylation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007064;mitotic sister chromatid cohesion
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0035864;response to potassium ion
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:2000615;regulation of histone H3-K9 acetylation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0080182;histone H3-K4 trimethylation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0045725;positive regulation of glycogen biosynthetic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0048172;regulation of short-term neuronal synaptic plasticity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0051571;positive regulation of histone H3-K4 methylation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0060216;definitive hemopoiesis
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0071459;protein localization to chromosome, centromeric region
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0043984;histone H4-K16 acetylation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0042771;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
|
3 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0048873;homeostasis of number of cells within a tissue
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0048536;spleen development
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:0042992;negative regulation of transcription factor import into nucleus
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006306;DNA methylation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0042308;negative regulation of protein import into nucleus
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051899;membrane depolarization
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007224;smoothened signaling pathway
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0009791;post-embryonic development
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0045652;regulation of megakaryocyte differentiation
|
3 |
1 |
0 |
1 |
0 |
0 |
BP |
Unclassified; |
GO:0042990;regulation of transcription factor import into nucleus
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0032411;positive regulation of transporter activity
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1902036;regulation of hematopoietic stem cell differentiation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0009952;anterior/posterior pattern specification
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0071339;MLL1 complex
|
3 |
0 |
0 |
1 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005819;spindle
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0072354;histone kinase activity (H3-T3 specific)
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0045322;unmethylated CpG binding
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0003680;AT DNA binding
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0042800;histone methyltransferase activity (H3-K4 specific)
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0070577;lysine-acetylated histone binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
Unclassified; |
GO:0140030;modification-dependent protein binding
|
5 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0007610;behavior |
GO:0007622;rhythmic behavior
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0090140;regulation of mitochondrial fission
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0046939;nucleotide phosphorylation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0031110;regulation of microtubule polymerization or depolymerization
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016641;oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0019200;carbohydrate kinase activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010972;negative regulation of G2/M transition of mitotic cell cycle
|
3 |
0 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:0042787;protein ubiquitination involved in ubiquitin-dependent protein catabolic process
|
3 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle
|
3 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0010611;regulation of cardiac muscle hypertrophy
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0008028;monocarboxylic acid transmembrane transporter activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070234;positive regulation of T cell apoptotic process
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0030485;smooth muscle contractile fiber
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0036317;tyrosyl-RNA phosphodiesterase activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0052692;raffinose alpha-galactosidase activity
|
3 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043402;glucocorticoid mediated signaling pathway
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006352;DNA-templated transcription, initiation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0031668;cellular response to extracellular stimulus
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0001505;regulation of neurotransmitter levels
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0098656;anion transmembrane transport
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0046942;carboxylic acid transport
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0038051;glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015081;sodium ion transmembrane transporter activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0008514;organic anion transmembrane transporter activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071870;cellular response to catecholamine stimulus
|
11 |
2 |
0 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0031325;positive regulation of cellular metabolic process
|
11 |
2 |
0 |
4 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0051186;cofactor metabolic process
|
3 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0035902;response to immobilization stress
|
4 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0002429;immune response-activating cell surface receptor signaling pathway
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0030054;cell junction |
GO:0005911;cell-cell junction
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0001772;immunological synapse
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0016235;aggresome
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0048550;negative regulation of pinocytosis
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051006;positive regulation of lipoprotein lipase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010867;positive regulation of triglyceride biosynthetic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0010875;positive regulation of cholesterol efflux
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0045723;positive regulation of fatty acid biosynthetic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0032369;negative regulation of lipid transport
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0001133;RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0034191;apolipoprotein A-I receptor binding
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0099080;supramolecular complex |
GO:0099512;supramolecular fiber
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0035589;G-protein coupled purinergic nucleotide receptor signaling pathway
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0045028;G-protein coupled purinergic nucleotide receptor activity
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0045029;UDP-activated nucleotide receptor activity
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:0061857;endoplasmic reticulum stress-induced pre-emptive quality control
|
3 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0050883;musculoskeletal movement, spinal reflex action
|
3 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1903378;positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway
|
3 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0030594;neurotransmitter receptor activity
|
5 |
3 |
0 |
2 |
0 |
1 |
CC |
GO:0043226;organelle |
GO:0005874;microtubule
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0031647;regulation of protein stability
|
1 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:1990589;ATF4-CREB1 transcription factor complex
|
1 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0031253;cell projection membrane
|
4 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0031224;intrinsic component of membrane
|
3 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0001547;antral ovarian follicle growth
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0071840;cellular component organization or biogenesis |
GO:2000707;positive regulation of dense core granule biogenesis
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0090188;negative regulation of pancreatic juice secretion
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0000988;transcription factor activity, protein binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0000981;RNA polymerase II transcription factor activity, sequence-specific DNA binding
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0048538;thymus development
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:2001150;positive regulation of dipeptide transmembrane transport
|
3 |
2 |
0 |
3 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0016321;female meiosis chromosome segregation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:0045143;homologous chromosome segregation
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0000922;spindle pole
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0033182;regulation of histone ubiquitination
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0000729;DNA double-strand break processing
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070423;nucleotide-binding oligomerization domain containing signaling pathway
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070911;global genome nucleotide-excision repair
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0070534;protein K63-linked ubiquitination
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0045739;positive regulation of DNA repair
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006301;postreplication repair
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006303;double-strand break repair via nonhomologous end joining
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0031058;positive regulation of histone modification
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051443;positive regulation of ubiquitin-protein transferase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0000151;ubiquitin ligase complex
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0043130;ubiquitin binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0061630;ubiquitin protein ligase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0046658;anchored component of plasma membrane
|
2 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0030658;transport vesicle membrane
|
4 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0000785;chromatin
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:1900215;negative regulation of apoptotic process involved in metanephric collecting duct development
|
5 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:1900218;negative regulation of apoptotic process involved in metanephric nephron tubule development
|
6 |
3 |
0 |
3 |
0 |
1 |
MF |
GO:0140110;transcription regulator activity |
GO:0000982;transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding
|
3 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016853;isomerase activity
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0009914;hormone transport
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0004888;transmembrane signaling receptor activity
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:1905898;positive regulation of response to endoplasmic reticulum stress
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1903573;negative regulation of response to endoplasmic reticulum stress
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0098562;cytoplasmic side of membrane
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004721;phosphoprotein phosphatase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006583;melanin biosynthetic process from tyrosine
|
1 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0033162;melanosome membrane
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004503;monophenol monooxygenase activity
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0072061;inner medullary collecting duct development
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0045939;negative regulation of steroid metabolic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0070980;biphenyl catabolic process
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0035579;specific granule membrane
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0030427;site of polarized growth
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:2001213;negative regulation of vasculogenesis
|
9 |
4 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0030947;regulation of vascular endothelial growth factor receptor signaling pathway
|
2 |
2 |
1 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0060574;intestinal epithelial cell maturation
|
2 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0070901;mitochondrial tRNA methylation
|
1 |
1 |
1 |
0 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0044798;nuclear transcription factor complex
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0035035;histone acetyltransferase binding
|
6 |
3 |
1 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0047006;17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0047035;testosterone dehydrogenase (NAD+) activity
|
1 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0009295;nucleoid |
GO:0042645;mitochondrial nucleoid
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0055072;iron ion homeostasis
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0097191;extrinsic apoptotic signaling pathway
|
1 |
1 |
1 |
0 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0031264;death-inducing signaling complex
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016929;SUMO-specific protease activity
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0019784;NEDD8-specific protease activity
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0098772;molecular function regulator |
GO:0016004;phospholipase activator activity
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0098772;molecular function regulator |
GO:0004861;cyclin-dependent protein serine/threonine kinase inhibitor activity
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0086002;cardiac muscle cell action potential involved in contraction
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0023052;signaling |
GO:0086091;regulation of heart rate by cardiac conduction
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0098912;membrane depolarization during atrial cardiac muscle cell action potential
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0086045;membrane depolarization during AV node cell action potential
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0034703;cation channel complex
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:1990454;L-type voltage-gated calcium channel complex
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0005261;cation channel activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0032273;positive regulation of protein polymerization
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0006897;endocytosis
|
2 |
2 |
0 |
2 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0005765;lysosomal membrane
|
2 |
2 |
0 |
2 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0005525;GTP binding
|
2 |
2 |
0 |
2 |
0 |
1 |
BP |
GO:0008283;cell proliferation |
GO:0060502;epithelial cell proliferation involved in lung morphogenesis
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1903034;regulation of response to wounding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
Unclassified; |
GO:0004728;signal transducer, downstream of receptor, with protein tyrosine phosphatase activity
|
3 |
2 |
0 |
1 |
0 |
1 |
MF |
GO:0098772;molecular function regulator |
GO:0043539;protein serine/threonine kinase activator activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0098772;molecular function regulator |
GO:0019887;protein kinase regulator activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0090316;positive regulation of intracellular protein transport
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044456;synapse part |
GO:0098793;presynapse
|
5 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0008156;negative regulation of DNA replication
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0032206;positive regulation of telomere maintenance
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0034644;cellular response to UV
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:2001022;positive regulation of response to DNA damage stimulus
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010743;regulation of macrophage derived foam cell differentiation
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0001227;transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding
|
3 |
3 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1904456;negative regulation of neuronal action potential
|
2 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0060205;cytoplasmic vesicle lumen
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:1990837;sequence-specific double-stranded DNA binding
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0010469;regulation of receptor activity
|
1 |
0 |
0 |
1 |
0 |
1 |
BP |
GO:0065007;biological regulation |
GO:0055064;chloride ion homeostasis
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007088;regulation of mitotic nuclear division
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0035064;methylated histone binding
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0010952;positive regulation of peptidase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0051641;cellular localization
|
2 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0043281;regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0036459;thiol-dependent ubiquitinyl hydrolase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002361;CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation
|
8 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0042355;L-fucose catabolic process
|
8 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0036065;fucosylation
|
8 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006672;ceramide metabolic process
|
8 |
2 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:2001275;positive regulation of glucose import in response to insulin stimulus
|
3 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0000791;euchromatin
|
3 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0044422;organelle part |
GO:0097165;nuclear stress granule
|
4 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0061770;translation elongation factor binding
|
4 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0003968;RNA-directed 5'-3' RNA polymerase activity
|
4 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051427;hormone receptor binding
|
3 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0043565;sequence-specific DNA binding
|
3 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006679;glucosylceramide biosynthetic process
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0009605;response to external stimulus
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0044262;cellular carbohydrate metabolic process
|
3 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0031960;response to corticosteroid
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006665;sphingolipid metabolic process
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0010565;regulation of cellular ketone metabolic process
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010822;positive regulation of mitochondrion organization
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
Unclassified; |
GO:0102769;dihydroceramide glucosyltransferase activity
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0008120;ceramide glucosyltransferase activity
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016757;transferase activity, transferring glycosyl groups
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0090398;cellular senescence
|
9 |
5 |
0 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0009931;calcium-dependent protein serine/threonine kinase activity
|
9 |
5 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051019;mitogen-activated protein kinase binding
|
9 |
5 |
0 |
2 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0042162;telomeric DNA binding
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043518;negative regulation of DNA damage response, signal transduction by p53 class mediator
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0048025;negative regulation of mRNA splicing, via spliceosome
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0090312;positive regulation of protein deacetylation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0045332;phospholipid translocation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:0072089;stem cell proliferation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0000381;regulation of alternative mRNA splicing, via spliceosome
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0000086;G2/M transition of mitotic cell cycle
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0048156;tau protein binding
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0032637;interleukin-8 production
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
Unclassified; |
GO:0044240;multicellular organismal lipid catabolic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002446;neutrophil mediated immunity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0036149;phosphatidylinositol acyl-chain remodeling
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0036148;phosphatidylglycerol acyl-chain remodeling
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0019370;leukotriene biosynthetic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0036150;phosphatidylserine acyl-chain remodeling
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002227;innate immune response in mucosa
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0036152;phosphatidylethanolamine acyl-chain remodeling
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0036151;phosphatidylcholine acyl-chain remodeling
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0019731;antibacterial humoral response
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006654;phosphatidic acid biosynthetic process
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
Unclassified; |
GO:0061844;antimicrobial humoral immune response mediated by antimicrobial peptide
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010524;positive regulation of calcium ion transport into cytosol
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0008645;hexose transport
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0032869;cellular response to insulin stimulus
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0008643;carbohydrate transport
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006633;fatty acid biosynthetic process
|
2 |
1 |
0 |
2 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0050830;defense response to Gram-positive bacterium
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007015;actin filament organization
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0050778;positive regulation of immune response
|
2 |
2 |
0 |
2 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0047498;calcium-dependent phospholipase A2 activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
Unclassified; |
GO:0102567;phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
Unclassified; |
GO:0102568;phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0005509;calcium ion binding
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0000806;Y chromosome
|
2 |
2 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0097134;cyclin E1-CDK2 complex
|
2 |
2 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0097135;cyclin E2-CDK2 complex
|
2 |
2 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0097123;cyclin A1-CDK2 complex
|
2 |
2 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0097124;cyclin A2-CDK2 complex
|
2 |
2 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0032970;regulation of actin filament-based process
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0032412;regulation of ion transmembrane transporter activity
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0051924;regulation of calcium ion transport
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0097252;oligodendrocyte apoptotic process
|
4 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0072289;metanephric nephron tubule formation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0072716;response to actinomycin D
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0001228;transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding
|
2 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0016600;flotillin complex
|
3 |
3 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0015629;actin cytoskeleton
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0051604;protein maturation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051098;regulation of binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0008235;metalloexopeptidase activity
|
2 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0018206;peptidyl-methionine modification
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0022400;regulation of rhodopsin mediated signaling pathway
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0031365;N-terminal protein amino acid modification
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016485;protein processing
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0095500;acetylcholine receptor signaling pathway
|
4 |
4 |
1 |
1 |
0 |
1 |
BP |
GO:0023052;signaling |
GO:0007274;neuromuscular synaptic transmission
|
4 |
4 |
1 |
1 |
0 |
1 |
CC |
GO:0030054;cell junction |
GO:0046581;intercellular canaliculus
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
Unclassified; |
GO:0071438;invadopodium membrane
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0022848;acetylcholine-gated cation-selective channel activity
|
4 |
4 |
1 |
1 |
0 |
1 |
MF |
GO:0060089;molecular transducer activity |
GO:0015464;acetylcholine receptor activity
|
4 |
4 |
1 |
1 |
0 |
1 |
BP |
GO:0009987;cellular process |
GO:0030968;endoplasmic reticulum unfolded protein response
|
1 |
1 |
0 |
1 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0005778;peroxisomal membrane
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0001676;long-chain fatty acid metabolic process
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0031226;intrinsic component of plasma membrane
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0022414;reproductive process |
GO:0060135;maternal process involved in female pregnancy
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0060415;muscle tissue morphogenesis
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0042692;muscle cell differentiation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0001654;eye development
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0050648;5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0050647;5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0050646;5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006178;guanine salvage
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1905225;response to thyrotropin-releasing hormone
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0052657;guanine phosphoribosyltransferase activity
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004422;hypoxanthine phosphoribosyltransferase activity
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0016936;galactoside binding
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0050877;nervous system process
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0007585;respiratory gaseous exchange
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0046825;regulation of protein export from nucleus
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
Unclassified; |
GO:0005049;nuclear export signal receptor activity
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
Unclassified; |
GO:0005487;nucleocytoplasmic transporter activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0060078;regulation of postsynaptic membrane potential
|
1 |
1 |
1 |
0 |
0 |
1 |
CC |
GO:0044464;cell part |
GO:0036126;sperm flagellum
|
2 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0030819;positive regulation of cAMP biosynthetic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0051898;negative regulation of protein kinase B signaling
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0005889;hydrogen:potassium-exchanging ATPase complex
|
3 |
2 |
0 |
2 |
0 |
1 |
MF |
GO:0005215;transporter activity |
GO:0008900;hydrogen:potassium-exchanging ATPase activity
|
3 |
2 |
0 |
2 |
0 |
1 |
MF |
GO:0005215;transporter activity |
GO:0005391;sodium:potassium-exchanging ATPase activity
|
3 |
2 |
0 |
2 |
0 |
1 |
MF |
GO:0003824;catalytic activity |
GO:0017111;nucleoside-triphosphatase activity
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0005215;transporter activity
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016052;carbohydrate catabolic process
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0019935;cyclic-nucleotide-mediated signaling
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0140110;transcription regulator activity |
GO:0001106;RNA polymerase II transcription corepressor activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1990418;response to insulin-like growth factor stimulus
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0035470;positive regulation of vascular wound healing
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006990;positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0035326;enhancer binding
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0061179;negative regulation of insulin secretion involved in cellular response to glucose stimulus
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010666;positive regulation of cardiac muscle cell apoptotic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0015936;coenzyme A metabolic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006743;ubiquinone metabolic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0045445;myoblast differentiation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0008299;isoprenoid biosynthetic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0048643;positive regulation of skeletal muscle tissue development
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010664;negative regulation of striated muscle cell apoptotic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:0097756;negative regulation of blood vessel diameter
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0045540;regulation of cholesterol biosynthetic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0061045;negative regulation of wound healing
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0032874;positive regulation of stress-activated MAPK cascade
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004420;hydroxymethylglutaryl-CoA reductase (NADPH) activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0042282;hydroxymethylglutaryl-CoA reductase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0070402;NADPH binding
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
Unclassified; |
GO:0035786;protein complex oligomerization
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0072757;cellular response to camptothecin
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0044806;G-quadruplex DNA unwinding
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0048478;replication fork protection
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0072711;cellular response to hydroxyurea
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0061820;telomeric D-loop disassembly
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005730;nucleolus
|
2 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0061749;forked DNA-dependent helicase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
Unclassified; |
GO:0061849;telomeric G-quadruplex DNA binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:1905773;8-hydroxy-2'-deoxyguanosine DNA binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0000403;Y-form DNA binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0000405;bubble DNA binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051880;G-quadruplex DNA binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004844;uracil DNA N-glycosylase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070207;protein homotrimerization
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043523;regulation of neuron apoptotic process
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0005640;nuclear outer membrane
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0005637;nuclear inner membrane
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:1904213;negative regulation of iodide transmembrane transport
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0042587;glycogen granule
|
2 |
0 |
0 |
2 |
0 |
0 |
CC |
GO:0044464;cell part |
GO:0005782;peroxisomal matrix
|
1 |
0 |
0 |
1 |
0 |
0 |
MF |
GO:0016209;antioxidant activity |
GO:0004601;peroxidase activity
|
3 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0050661;NADP binding
|
1 |
0 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004319;enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity
|
1 |
0 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070101;positive regulation of chemokine-mediated signaling pathway
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0061419;positive regulation of transcription from RNA polymerase II promoter in response to hypoxia
|
2 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0001012;RNA polymerase II regulatory region DNA binding
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0016020;membrane |
GO:0005743;mitochondrial inner membrane
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0000930;gamma-tubulin complex
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0045202;synapse |
GO:0060076;excitatory synapse
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0072422;signal transduction involved in DNA damage checkpoint
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0072395;signal transduction involved in cell cycle checkpoint
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0003887;DNA-directed DNA polymerase activity
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0072434;signal transduction involved in mitotic G2 DNA damage checkpoint
|
1 |
1 |
1 |
0 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:1990391;DNA repair complex
|
1 |
1 |
1 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0045335;phagocytic vesicle
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004677;DNA-dependent protein kinase activity
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016303;1-phosphatidylinositol-3-kinase activity
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0031571;mitotic G1 DNA damage checkpoint
|
1 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0000805;X chromosome
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0043666;regulation of phosphoprotein phosphatase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0035409;histone H3-Y41 phosphorylation
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0031904;endosome lumen
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0035401;histone kinase activity (H3-Y41 specific)
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0005131;growth hormone receptor binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0005143;interleukin-12 receptor binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0031702;type 1 angiotensin receptor binding
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051097;negative regulation of helicase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0072717;cellular response to actinomycin D
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0090403;oxidative stress-induced premature senescence
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070245;positive regulation of thymocyte apoptotic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0051974;negative regulation of telomerase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006983;ER overload response
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:1990440;positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:0008340;determination of adult lifespan
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1900119;positive regulation of execution phase of apoptosis
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006978;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0031065;positive regulation of histone deacetylation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0046827;positive regulation of protein export from nucleus
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0048511;rhythmic process |
GO:0048512;circadian behavior
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0032461;positive regulation of protein oligomerization
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0031497;chromatin assembly
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0035025;positive regulation of Rho protein signal transduction
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1900740;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0090200;positive regulation of release of cytochrome c from mitochondria
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:0048147;negative regulation of fibroblast proliferation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:1903205;regulation of hydrogen peroxide-induced cell death
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0010165;response to X-ray
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0043525;positive regulation of neuron apoptotic process
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0070098;chemokine-mediated signaling pathway
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051453;regulation of intracellular pH
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006289;nucleotide-excision repair
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002687;positive regulation of leukocyte migration
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0030308;negative regulation of cell growth
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006914;autophagy
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0016494;C-X-C chemokine receptor activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0005507;copper ion binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0003730;mRNA 3'-UTR binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0051087;chaperone binding
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0008022;protein C-terminus binding
|
2 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0051480;regulation of cytosolic calcium ion concentration
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0051656;establishment of organelle localization
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0006814;sodium ion transport
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0090559;regulation of membrane permeability
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0008283;cell proliferation |
GO:0048145;regulation of fibroblast proliferation
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051704;multi-organism process |
GO:0070946;neutrophil mediated killing of gram-positive bacterium
|
3 |
2 |
0 |
2 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0010941;regulation of cell death
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0033754;indoleamine 2,3-dioxygenase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0004833;tryptophan 2,3-dioxygenase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0008637;apoptotic mitochondrial changes
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0015267;channel activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
Unclassified; |
GO:0015266;protein channel activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0005215;transporter activity |
GO:0008320;protein transmembrane transporter activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0061663;NEDD8 ligase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0071109;superior temporal gyrus development
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:2000077;negative regulation of type B pancreatic cell development
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:2000466;negative regulation of glycogen (starch) synthase activity
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0032501;multicellular organismal process |
GO:1904339;negative regulation of dopaminergic neuron differentiation
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002906;negative regulation of mature B cell apoptotic process
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:1990909;Wnt signalosome
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:0030877;beta-catenin destruction complex
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0034236;protein kinase A catalytic subunit binding
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071732;cellular response to nitric oxide
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0002248;connective tissue replacement involved in inflammatory response wound healing
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0070888;E-box binding
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:1902912;pyruvate kinase complex
|
1 |
0 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005929;cilium
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0040007;growth |
GO:0044130;negative regulation of growth of symbiont in host
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0043394;proteoglycan binding
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
Unclassified; |
GO:0005575;cellular_component
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0002930;trabecular meshwork development
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0032991;macromolecular complex |
GO:1902554;serine/threonine protein kinase complex
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0033743;peptide-methionine (R)-S-oxide reductase activity
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0047134;protein-disulfide reductase activity
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016651;oxidoreductase activity, acting on NAD(P)H
|
1 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0001725;stress fiber
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016174;NAD(P)H oxidase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
MF |
GO:0003824;catalytic activity |
GO:0016175;superoxide-generating NADPH oxidase activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0046326;positive regulation of glucose import
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:1904843;cellular response to nitroglycerin
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0061408;positive regulation of transcription from RNA polymerase II promoter in response to heat stress
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
Unclassified; |
GO:0030529;intracellular ribonucleoprotein complex
|
1 |
1 |
0 |
1 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0000049;tRNA binding
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0098869;cellular oxidant detoxification
|
1 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0050896;response to stimulus |
GO:0071471;cellular response to non-ionic osmotic stress
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0065007;biological regulation |
GO:0035633;maintenance of permeability of blood-brain barrier
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0071284;cellular response to lead ion
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0006975;DNA damage induced protein phosphorylation
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0032502;developmental process |
GO:0060324;face development
|
2 |
1 |
0 |
0 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0005815;microtubule organizing center
|
2 |
1 |
0 |
0 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0016569;covalent chromatin modification
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0009987;cellular process |
GO:0007214;gamma-aminobutyric acid signaling pathway
|
1 |
1 |
1 |
0 |
0 |
0 |
BP |
GO:0051179;localization |
GO:0051939;gamma-aminobutyric acid import
|
1 |
1 |
1 |
0 |
0 |
0 |
CC |
GO:0044425;membrane part |
GO:0038039;G-protein coupled receptor heterodimeric complex
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0060089;molecular transducer activity |
GO:0016917;GABA receptor activity
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0098772;molecular function regulator |
GO:0048018;receptor ligand activity
|
1 |
0 |
0 |
0 |
0 |
0 |
BP |
GO:0002376;immune system process |
GO:0002224;toll-like receptor signaling pathway
|
1 |
1 |
0 |
1 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0097708;intracellular vesicle
|
1 |
1 |
0 |
1 |
0 |
0 |
BP |
GO:0008152;metabolic process |
GO:0006091;generation of precursor metabolites and energy
|
1 |
1 |
1 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0043178;alcohol binding
|
1 |
0 |
0 |
1 |
0 |
0 |
CC |
GO:0043226;organelle |
GO:0015630;microtubule cytoskeleton
|
1 |
1 |
0 |
1 |
0 |
1 |
MF |
GO:0005488;binding |
GO:0046872;metal ion binding
|
1 |
1 |
0 |
0 |
0 |
0 |
MF |
GO:0005488;binding |
GO:0031748;D1 dopamine receptor binding
|
1 |
1 |
0 |
1 |
0 |
0 |